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ABSTRACT
 Perinatal regionalization systems have been shown to reduce the risk of neonatal 
mortality when very low birth weight infants are delivered in Level III hospitals with 
neonatal intensive care units, sub-specialist staffing, and adequate experience caring for 
high-risk pregnancies and neonates.  However, studies to date examining the association 
between delivery in Level III hospitals and neonatal mortality have not accounted for 
censoring due to fetal deaths.  Furthermore, studies of perinatal regionalization to date 
have not adequately assessed the association between delivery hospital level of care and 
the infant’s hospital length of stay.  This dissertation examined 8,594 very low birth 
weight live births and fetal deaths occurring in South Carolina hospitals from 2004-2013 
to assess the association between birth in a non-Level III hospital and neonatal mortality 
accounting for censoring due to fetal death through the use of marginal structural models.  
Subsequently, a simulation study was conducted to identify the most appropriate 
statistical regression models to analyze highly skewed outcomes such as hospital length 
of stay.  Finally, Laplace regression was used to assess the association between delivery 
hospital level of care and hospital length of stay among 6,301 live born very low birth 
weight infants delivered in South Carolina hospitals from 2004-2013.  These analyses 
found that very low birth weight infants delivered in a non-Level III hospital had a 
statistically significantly greater risk of neonatal death than similar infants delivered in a 
Level III hospital (aRR=1.81, 95% CI: 1.52, 2.15).  Furthermore, Laplace regression was 
determined to be the most effective method for analyzing highly skewed outcomes when 
vi 
the underlying distribution giving rise to the outcome is not confidently known.  Finally, 
hospital length of stay was found to be statistically significantly shorter for very low birth 
weight infants delivered at Level I or Level II hospitals than similar infants born in Level 
III hospitals for relatively short lengths of stay (5th and 10th conditional centiles); 
significantly shorter for very low birth weight infants delivered at Level II hospitals than 
similar infants born in Level III hospitals for relatively central lengths of stay (25th, 50th, 
and 75th conditional quantiles); but no statistically significantly different hospital lengths 
of stay were observed across levels of care for relatively long lengths of stay (90th and 
95th conditional centiles).  The potential cost savings due to shorter hospital stays among 
relatively short and central hospital lengths of stay do not outweigh the increased risk of 
neonatal mortality when very low birth weight infants are delivered in non-Level III 
hospitals.  Therefore, it is recommended that South Carolina maintain the perinatal 
regionalization system and seek to ensure that every possible high-risk pregnancy has the 
opportunity to deliver at a hospital with a neonatal intensive care unit.
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CHAPTER 1 
INTRODUCTION
The purpose of this chapter is to provide background information about infant mortality 
and perinatal regionalization in South Carolina.  Additionally, this chapter will establish 
the format and structure of this dissertation. 
 
Infant Mortality 
Infant mortality is a major public health outcome used in South Carolina (SC), the 
United States (US), and across the world as an indicator of overall population health1 and, 
in particular, the health of the women of reproductive age2,3.  In the US, infant mortality 
has decreased from 9.81 deaths per 1,000 live births in 1989 to 5.98 deaths per 1,000 live 
births in 20124.  However, despite these decreases in infant mortality, the US continues to 
have substantially higher infant mortality rates than many other developed nations, 
particularly due to a higher prevalence of preterm births5.  Among US states, those in the 
Southeast have substantially higher infant mortality rates, with 1.18 excess infant deaths 
for every 1,000 live births than other US regions6.   
 South Carolina’s infant mortality rate has decreased substantially over the past 
decade, from 9.3 deaths per 1,000 live births in 2004 to 6.9 deaths per 1,000 live births in 
20137.  Disorders related to low birth weight or short gestation are consistently the first or 
second leading cause of infant death annually in SC.  Compared to normal birth weight 
infants, infants born with a very low birth weight (VLBW; <1,500 grams) are 
2 
 
substantially more likely to die in the first year of life, with most of these deaths 
occurring during the neonatal period (first 27 days of life).  Very low birth weight 
deliveries made up 1.8% of all live births in SC in 2013, but comprised 54.5% of all 
infant deaths in 2013.  Among these deaths to VLBW infants, 86.3% occurred during the 
neonatal period.  Therefore, any system or intervention that effectively prevents VLBW 
births or reduces the risk of neonatal death among VLBW births has the potential to 
substantially impact the overall infant mortality rate. 
 
Components of Perinatal Regionalization 
 Perinatal regionalization is a system of care that seeks to ensure that women with 
high-risk pregnancies receive care and deliver at facilities with the technology, sub-
specialty staff, and experience to provide care for those high-risk pregnancies and 
resulting infants.  This is often referred to as a system of risk-appropriate care.  Perinatal 
regionalization systems are often statewide and classify hospitals into different levels of 
care based on factors such as specialist and sub-specialist staffing (e.g. maternal-fetal 
medicine specialists, neonatologists), technological capability to provide infant care (e.g. 
special care nurseries, neonatal intensive care units [NICUs]), and capability to perform 
complex cardiac surgeries on newborns.  Each state (or other geographic area) is divided 
into regions with at least one delivering hospital with a NICU and sub-specialist staff in 
each region.  These hospitals are referred to as Regional Perinatal Centers (RPCs) and 
provide the following services within their region: 
1. Act as the designated consultation and referral center for all high-risk 
pregnancies in the region,   
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2. Provide transportation for high-risk patients to get from community hospitals or 
midsize hospitals to the RPC, 
3. Provide clinician education programs through outreach educators, and 
4. Monitor the operation and effectiveness of the system within their region.  
All of these services are supported and facilitated by a series of contracts between 
hospitals in each region and the RPCs and between the RPCs and a funding agency, 
usually a state health department.  Perinatal regionalization systems have been shown to 
reduce the risk of neonatal mortality among VLBW infants8–13.  However, not all US 
states have perinatal regionalization systems and there are many differences in the way 
these systems operate among states that do have systems14. 
 
Perinatal Regionalization in South Carolina 
 In SC, hospitals licensed to care for pregnant women and deliver infants are 
currently divided into the following levels: Level I, Level II, Level II Enhanced 
(commonly referred to as Level IIE), Level III, and RPCs.  Level I hospitals are small 
community hospitals that provide care for uncomplicated pregnancies expected to result 
in normal birth weight births (≥2,500 grams).  Level II hospitals are larger hospitals with 
special care nurseries which provide appropriate care for some complex pregnancies 
expected to result in a normal birth weight or moderately low birth weight births (1,500 - 
2,499 gram).  Level IIE hospitals have special care nurseries with some additional 
capabilities to care for infants with a birth weight down to 1,250 grams.  Level III 
hospitals have 24 hour coverage by both maternal-fetal medicine specialists and 
neonatologists as well as NICUs that are equipped to provide appropriate care to normal 
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or complex pregnancies and infants of any birth weight.  Regional Perinatal Centers are 
Level III hospitals that accept high-risk pregnancies referred by other hospitals in their 
region, provide transportation for these women and infants, and provide educational 
programs to the other hospitals in their region.   
In SC, the criteria for hospitals to operate at each level of care are codified in SC 
State Regulation 61-16 and approved by the SC General Assembly.  Each hospital must 
apply to the SC Department of Health and Environmental Control (DHEC) Bureau of 
Health Facilities Licensing for licensure at a specified level before being approved to 
establish a maternity program.  South Carolina has four perinatal regions with at least at 
least one RPC in each region.  These perinatal regions and RPCs are identified in Figure 
1.1. 
The national conversation about perinatal regionalization began in 1976 when the 
March of Dimes Committee on Perinatal Health published Toward Improving the 
Outcome of Pregnancy: Recommendations for the Regional Development of Maternal 
and Perinatal Health Services15.  This document outlined a recommended structure for a 
regionalized system of perinatal care for the first time.  However, South Carolina had one 
of the three highest infant mortality rates in the US at this time, and a regionalized system 
of perinatal care was already being discussed among state health leaders.  In 1974 the SC 
Board of Health and Environment approved the South Carolina Regionalization of 
Perinatal Health Care Plan to allow for the voluntary review and designation of 
delivering hospitals in SC as Level I, Level II, or Level III care centers.  This plan also 
called for public funds for educational systems among health care providers. 
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In 1984, the Governor’s Perinatal Plan of Action was released by the 
administration of SC Governor Richard Riley.  This document, compiled by a multi-
agency work group, required DHEC to use its Certificate of Need (CON) process to 
develop standards and requirements for a hospital to have NICU beds, develop a 
licensure process for Level III hospitals, and develop and implement a transportation 
system to allow women with high-risk pregnancies to receive care at Level III facilities.  
This laid the foundation for the establishment of a formal, regulated perinatal 
regionalization system in SC.  This system has changed slightly in SC in the intervening 
years, with licensing standards allowing for the addition of Level IIE hospitals, as long as 
there was not a Level III facility within 90 miles, in 2002.   
In 2012, the American College of Obstetricians and Gynecologists and the 
American Academy of Pediatrics released the Guidelines for Perinatal Care, 7th Edition, 
which provided updated recommendations for the regionalization of perinatal care16.  
Strong perinatal regionalization systems continued to be recommended, but a Level IV 
designation was recommended for hospitals able to perform complex cardiac surgery in 
addition to the staffing and NICU requirements of Level III hospitals.  Additionally, the 
7th edition of the Guidelines of Perinatal Care recommended that Level III hospitals 
maintain a “high volume” of VLBW deliveries.  Given this new recommendation and the 
fact that a Level IIE designation has never been part of a national recommendation for 
perinatal regionalization systems, in 2014 DHEC drafted a revision of the perinatal 
section of SC State Regulation 61-16 to govern the SC perinatal regionalization system.  
This draft regulation eliminates the Level IIE designation; adds a Level IV designation; 
and implements a required volume of at least 100 VLBW admissions, infants on assisted 
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ventilation for more than 24 hours, or infant surgeries for hospitals to become Level III, 
RPC, or Level IV facilities.  These drafted regulations were approved by the SC Board of 
Health and Environment, the SC House of Representatives, and the SC Senate and were 
implemented as part of the SC State Hospital Regulations on June 26, 2015. 
 
Format and Structure of Dissertation 
 This dissertation will be formatted using the manuscript style with three academic 
papers making up chapters 4-6.  Each of these academic papers will answer research 
questions as follows: 
o Manuscript 1 (chapter 4): 
 Research Question 1: Does hospital level of perinatal care impact neonatal 
deaths in South Carolina?   
 Research Question 2: Does “censoring” due to in-hospital fetal deaths 
introduce selection bias in assessments of the association between hospital 
level of perinatal care and neonatal mortality17? 
o Manuscript 2 (chapter 5): 
 Research Question 1: Should a hospital length of stay outcome be analyzed as 
a count outcome (zero-inflated poisson regression, negative binomial 
regression, quantile regression), a continuous outcome (linear regression, 
quantile regression), or a time-to-event outcome (accelerated failure time 
regression, Laplace regression)?  What situations (tail length, censoring 
percentage, etc.) impact optimization of each analysis method? 
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o Manuscript 3 (chapter 6): 
 Research Question 1: Does delivery in a level III hospital impact hospital 
length of stay among VLBW infants (maternal transport vs. neonatal or no 
transport)? 
Chapter 7 will include an overall conclusion that summarizes the results of the three 
papers presented in chapters 4-6. 
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Figure 1.1: Map of SC’s perinatal regions and Regional Perinatal Centers.
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CHAPTER 2 
LITERATURE REVIEW
The purpose of this chapter is to provide a summary of the existing literature on perinatal 
regionalization and highlight the current research gaps. 
 
As mentioned above, the national conversation regarding perinatal regionalization began 
in earnest in 1976 with the publication of Toward Improving the Outcome of Pregnancy: 
Recommendations for the Regional Development of Maternal and Perinatal Health 
Services by the March of Dimes Committee on Perinatal Health.  After the release of this 
document demonstration projects were established to document the impact of 
regionalized systems of perinatal care in applied settings18.  In the years that followed, 
observational studies in states establishing perinatal regionalization systems began to 
consistently demonstrate positive impacts on neonatal mortality among VLBW infants8–
11, including studies specific to SC12,13. 
 Political environments, enabling legislation, and numbers of hospitals with 
existing NICUs vary from state to state, which has led to a lack of consistency in the way 
that regionalized systems of perinatal care are implemented among states that have some 
form of regionalization14,19.  Currently, some states have regulated perinatal 
regionalization systems supported by legislation, some states have systems supported by 
voluntary agreements among hospitals, and some states have no system of regionalized 
perinatal care.  At least one study examining the policy environments of states with 
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regulated perinatal regionalization systems compared to states with no perinatal 
regionalization has determined that states with CON programs are a major supporting 
factor for perinatal regionalization20.  CON programs require hospitals to demonstrate a 
need in their service area before being approved to add or increase offerings in specified 
services.  Since the repeal of Federal legislation requiring CON programs in 1986, at least 
20 states have abolished CON requirements for health facility construction and 
expansion.  This has led to “de-regionalization” of perinatal systems in some states and 
allowed for NICUs to open in hospitals that have a low volume of VLBW deliveries.  
Multiple studies have shown NICUs with a low volume of VLBW deliveries (<100 
VLBW deliveries per year) have significantly increased risk of neonatal mortality among 
VLBW infants than NICUs with a high-volume of VLBW deliveries11,17,21–28.  
Additionally, the Patient Protection and Affordable Care Act has had unintended 
consequences that increase the incentive to “de-regionalize,” emphasizing a need for 
current, relevant studies to assess the effectiveness on perinatal regionalization systems29–
31.  
 The vast majority of studies on perinatal regionalization have focused on the 
impact of these coordinated systems of care on neonatal mortality among VLBW infants 
as a proxy for high-risk pregnancies.  While neonatal mortality is an outcome of great 
importance, there is also a need for studies on other important outcomes32.  Outcomes 
that have a clearly defined financial impact on health care payers are of particular 
relevance to the ongoing policy discussion around perinatal regionalization.  Recent 
studies have examined outcomes such as necrotizing enterocolitis, neurological 
impairments, gastroschisis, and Medicaid reimbursement, comparing outcomes when 
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deliveries occur in hospitals with NICUs compared to when deliveries occur in smaller 
hospitals and were transferred to hospitals with NICUs31,33,34.  Emerging issues that are 
impacting the implementation, effectiveness, and assessment of perinatal regionalization 
include the increasing use of telemedicine and emerging data analysis methodologies 
such as instrumental variable analysis17,27,35. 
 Current gaps in perinatal regionalization literature include assessing the impact of 
in-hospital fetal deaths on outcomes such as neonatal mortality and assessments of the 
impact of birth in a Level III or higher hospital on NICU length of stay and overall 
hospital length of stay.  Phibbs et al. noted that in-hospital fetal deaths may result in bias 
of the true impact of VLBW deliveries occurring in Level III or higher hospitals on 
neonatal mortality in 200717. Instances where high-risk pregnancies that end in fetal 
deaths are being cared for in Level III or higher hospitals are also products of perinatal 
regionalization systems and, therefore should be included in analyses.  There may be 
little etiologic difference between many in-hospital fetal deaths and VLBW infants that 
die in the neonatal period.  However, fetal deaths have not been included in most studies 
of perinatal regionalization to date because these studies are often based on data from 
birth certificates, which are only filed in the event of a live birth. According to SC 
hospital discharge data, there were 300 in-hospital fetal deaths in 2014.  Annually there 
are roughly 420 total infant deaths and 190 neonatal deaths among VLBW deliveries.  
These fetal deaths should be considered lost-to-follow up, or censored outcomes.  If the 
primary outcome of interest is neonatal death, assessing hospital level of care without 
considering fetal deaths could result in selection bias.  Therefore, fetal deaths likely 
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should be accounted for in analyses, as there are a substantial number of these outcomes 
and adjusting for them may substantially impact study results and implications. 
 One study to date assessed the association of hospital of birth and hospital length 
of stay in the context of a regionalized system of perinatal care13.  This study, published 
by Sanderson et al. in 2000 evaluated length of stay as a continuous outcome using linear 
regression with a log-transformed outcome to account for the lack of normality in the 
length of stay variable.  A variety of analysis methods are now available and used for 
assessing length of stay outcomes.  Therefore, the most appropriate analysis method for 
assessing the impact on NICU length of stay and overall hospital length of stay for 
VLBW infants delivered in Level III or higher hospital compared to those delivered in 
smaller facilities warrants additional consideration.
13 
 
CHAPTER 3 
METHODS
The purpose of this chapter is to describe the methods that will be used for the analyses in 
each of the three manuscripts presented in chapters four through six. 
 
Manuscript 1 
This study seeks to assess the association between hospital level of perinatal care and 
neonatal mortality among VLBW infants and to quantify the impact on inference of 
analyses of considering in-hospital fetal deaths as censored observations.  Marginal 
structural modelling will be used to assess the relative risk of neonatal mortality among 
VLBW infants delivered in Level III hospitals compared to VLBW infants born in 
hospitals with a lower perinatal care designation. This analysis will be conducted using a 
linked data file that includes data on live births and fetal deaths occurring to SC residents 
from 2008-2013.  This linked file will include data on fetal deaths reported on the SC 
Report of Fetal Death vital records certificate, live births from birth certificate data linked 
to infant deaths from death certificate data, and hospital discharge uniform billing (UB-
04) data for all live births and fetal deaths occurring in a hospital. 
 Marginal structural modelling estimates counterfactual contrasts using stabilized 
inverse probability weighting to create a pseudo-population to account for potential 
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confounders by balancing those confounders across levels of the independent variable of 
primary interest (delivery in a Level III hospital in this analysis for the present analysis).  
Marginal structural models also account for censoring (in-hospital fetal deaths in this 
analysis) by including a component in the stabilized inverse probability weight that 
accounts for censoring by modeling the predictors of censored values.  Therefore a 
marginal structural model accounting for censoring can be estimated with the results 
compared to those from a marginal structural model that does not account for censoring, 
with the divisor of the relative risks indicating the impact of censoring. 
 The analyses presented in this manuscript will be restricted to fetal deaths and 
VLBW deliveries occurring in SC hospitals.  The outcome variable will be neonatal 
mortality, defined as death from a live birth through the 27th day of life occurring in any 
location.  This outcome variable will be assessed from birth certificate and death 
certificate data. The independent variable of primary interest will be the level of perinatal 
care of the hospital of delivery.  This variable will be coded as delivery or fetal death in a 
Level III hospital compared to delivery or fetal death in a hospital with a lower 
designation and will be assessed from birth certificate data.  Illustrated in the directed 
acyclic graph (DAG) in Figure 3.1 the following variables will be included as 
confounders: maternal age (continuous; birth certificate data), maternal race (non-
Hispanic white, non-Hispanic African American, Hispanic and other; birth certificate 
data), maternal education (less than high school, high school graduate, more than high 
school; birth certificate data), initiation of prenatal care in the first trimester of pregnancy 
(yes, no; birth certificate data), method of delivery payment (private insurance, Medicaid, 
self-pay or other; birth certificate data), pre-pregnancy body mass index (obese, 
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overweight, or normal/underweight; birth certificate data), gestational diabetes (yes, no; 
birth certificate data), gestational hypertension or pre-eclampsia (yes, no; birth certificate 
data), surfactant replacement therapy during pregnancy (yes, no; birth certificate data), 
corticosteroid use during pregnancy (yes, no; birth certificate data), and assisted 
ventilation for newborn (yes, no; birth certificate data).  Furthermore, data will be 
restricted to only singleton deliveries without indication of birth defects on the associated 
birth certificate. 
 The DAG in Figure 3.1 indicates that fetal death is a common effect of several 
variables that confound the association between hospital level of perinatal care and 
neonatal mortality.  This, along with the fact that fetal deaths occur before neonatal 
deaths might occur (that is, fetal deaths are a competing risk for neonatal death), indicate 
that fetal death is a suitable candidate for consideration as a censoring event. 
 
Manuscript 2 
A variety of statistical approaches have been used to analyze inpatient length of hospital 
stay as an outcome of interest.  The only study to date to analyze length of hospital stay 
to assess the impact of delivery in a Level III hospital within a regionalized system of 
perinatal care used linear regression with a log-transformed outcome variable to account 
for the non-normal distribution of the length of stay13.  Linear regression with a log-
transformed outcome approach has also been used to assess the impact of a variety of 
characteristics associated with length of hospital stay36–39, however most of the studies 
using this method were published prior to 2001. 
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 Studies have also considered length of hospital inpatient stay to be a count 
outcome and have applied Poisson regression and negative binomial regression models in 
these analyses40–43.  A few studies have used survival analysis to examine length of 
hospital stay as an outcome using both semi-parametric (Cox proportional hazards 
regression)44–46 and parametric (accelerated failure time regression) models45,47,48.  Some 
recent studies used quantile regression models for which the length of hospital stay was 
considered a continuous variable49–52 and have used other quantile regression models 
extended for modeling count data53.  Finally, at least one study used Laplace regression to 
model hospital length of stay as a survival outcome for quantiles of interest54. 
 In this manuscript, data with a variety of potential length of stay distributions will 
be generated with analysis conducted considering length of hospital stay as continuous 
outcome (using linear regression and quantile regression), a count outcome (using 
Poisson regression, negative binomial regression, and quantile regression), and a survival 
outcome (using Cox proportional hazards regression, accelerated failure time regression, 
and Laplace regression).  The distribution of the simulated hospital length of stay 
distributions will be varied by the location of the peak, length of the tail, and percentage 
of censored data.  Each distribution will be simulated and analyzed with each method 
1,000 times with results evaluated based on the percentage of time that the true 
association between the simulated length of stay outcome and the independent variable is 
captured within the 95% confidence interval for each model. 
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Manuscript 3 
The distribution of the length of NICU stay among VLBW infants born in SC in 2013 is 
presented in Figure 3.2.  The analysis method that is identified as the most appropriate to 
analyze the length of stay distribution observed in this population in manuscript 2 will be 
applied to SC live births occurring from 2008 to 2013.  Data for this analysis will include 
birth certificate data linked to hospital discharge data.   
 Data for this analysis will be restricted to singleton live births occurring in SC 
hospitals without congenital anomalies reported in birth certificate data.  The outcome 
variable will be length of NICU stay in days from hospital discharge data and the 
independent variable of primary interest will be level of perinatal care of the delivery 
hospital from birth certificate data.  As illustrated in the DAG presented in Figure 3.3, the 
following potential confounding variables will be included from birth certificate data: 
maternal age (continuous), maternal race (non-Hispanic white, non-Hispanic African 
American, Hispanic and other), maternal education (less than high school, high school 
graduate, more than high school), initiation of prenatal care in the first trimester of 
pregnancy (yes, no), method of delivery payment (private insurance, Medicaid, self-pay 
or other), surfactant replacement therapy during pregnancy (yes, no), corticosteroid use 
during pregnancy (yes, no), and assisted ventilation for newborn (yes, no).   
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Figure 3.1: Directed acyclic graph (DAG) for the relationship between level of perinatal care for the hospital of delivery and neonatal 
mortality. 
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Figure 3.2: Distribution of total days until neonatal intensive care unit discharge among 2013 SC neonatal intensive care unit 
admissions. 
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Figure 3.3: Directed acyclic graph (DAG) for the relationship between level of perinatal care for the hospital of delivery and length of 
hospital stay.  
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CHAPTER 4 
 
ASSESSING THE ROLE OF CENSORING DUE TO FETAL DEATHS 
ON THE ASSOCIATION BETWEEN DELIVERY HOSPITAL LEVEL 
AND NEONATAL MORTALITY IN A REGIONALIZED SYSTEM OF 
PERINATAL CARE1
                                                          
1 Smith M.G., Fleischer N., Geraci M., Hale N., Hardin J.  Submitted to American 
Journal of Epidemiology, 02/20/2016 
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The purpose of this chapter is to describe the motivation, methods, results, and 
implications of an analysis examining the impact of the level of care of the hospital of 
birth on neonatal mortality among very low birth weight deliveries in South Carolina. 
 
Introduction 
Perinatal regionalization is a system of care that seeks to ensure that women with high-
risk pregnancies receive care and deliver at facilities with the appropriate technology, 
sub-specialty staff, and experience to provide care for those high-risk pregnancies and 
resulting infants16.  This system is often referred to as a system of risk-appropriate care.  
Perinatal regionalization systems are often statewide and classify hospitals into different 
levels of care based on factors such as specialist and sub-specialist staffing, technological 
capability to provide infant care, and capability to perform complex cardiac surgeries on 
newborns. These systems provide mechanisms to transfer the care of high-risk 
pregnancies to appropriate hospitals equipped with the staffing, technology, and 
experience to provide optimal care for the mother and fetus. Perinatal regionalization 
systems have been shown to reduce the risk of neonatal mortality among very low birth 
weight (VLBW; <1,500 grams) infants8–13.  However, not all US states have perinatal 
regionalization systems and there are many differences in the way these systems operate 
among states that do have systems14.  
In South Carolina (SC), hospitals licensed to care for pregnant women and deliver 
infants were  divided into the following levels from 2004-2013: Level I, Level II, Level II 
Enhanced (commonly referred to as Level IIE), Level III, and Regional Perinatal Centers 
(RPCs).  Level I hospitals are small community hospitals that provide care for 
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uncomplicated pregnancies expected to result in normal birth weight births (≥2,500 
grams).  Level II hospitals are larger hospitals with special care nurseries which provide 
appropriate care for some complex pregnancies expected to result in a normal birth 
weight or moderately low birth weight births (1,500 - 2,499 grams).  Level IIE hospitals 
have special care nurseries with some additional capabilities to care for infants with a 
birth weight down to 1,250 grams.  Level III hospitals have 24-hour coverage by both 
maternal-fetal medicine specialists and neonatologists as well as NICUs that are equipped 
to provide appropriate care to normal or complex pregnancies and infants of any birth 
weight.  RPCs are Level III hospitals that accept high-risk pregnancies referred by other 
hospitals in their region, provide transportation for these women and infants, and provide 
educational programs to the other hospitals in their region. In SC, the criteria for hospitals 
to operate at each level of care are codified in SC State Regulation 61-16 and approved 
by the SC General Assembly55.  In 2013 there were 17 Level I hospitals, 21 Level II 
hospitals, one Level IIE hospital, and seven Level III hospitals.  Five of the seven Level 
III hospital were RPCs.  These seven Level III hospitals delivered 35.8% of all live births 
occurring in SC.   
The majority of studies on perinatal regionalization have focused on the impact of 
regionalization on neonatal mortality among VLBW infants as a proxy for high-risk 
pregnancies8–13.  Neonatal mortality is defined as the death of a live-born infant in the 
first 27 days of life occurring in any location. However, high-risk pregnancies that are 
transferred to Level III hospitals and end in fetal deaths (the death of a fetus prior to 
delivery, also known as stillbirth) also represent instances of a perinatal regionalization 
system providing risk-appropriate care. Therefore, a comprehensive analysis of a 
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perinatal regionalization system should also take the impact of fetal deaths occurring 
inside and outside Level III hospitals into consideration.  There may be little etiologic 
difference between many in-hospital fetal deaths and VLBW infants that die in the 
neonatal period.  However, fetal deaths are rarely (for exceptions, see references 11,17) 
included in many studies of perinatal regionalization to date because these studies are 
often based on data from birth certificates, which are only filed in the event of a live 
birth. 
This paper assesses the association between the level of perinatal care of the 
delivery hospital and neonatal mortality among high-risk deliveries in order to evaluate 
the impact of SC’s perinatal regionalization system.  Furthermore, our investigation 
explores whether treating fetal deaths as censored observations impacts the association 
between the delivering hospital level of perinatal care and neonatal mortality among 
VLBW live births. 
Methods 
Data 
This analysis utilizes a linked data file that includes data on live births and fetal deaths 
occurring among SC residents delivering in SC from 2004-2013.  This linked file 
includes data on fetal deaths reported on the SC Report of Fetal Death vital records 
certificate, live births from the SC Certificate of Live Birth (2003 US Standard revision), 
infant deaths from the SC Certificate of Death, and hospital discharge uniform billing 
(UB-04) data for all live births and fetal deaths occurring in a hospital. 
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 The primary outcome of interest in these analyses is neonatal mortality, which is 
assessed from death certificate data.  The primary independent variable of interest is the 
level of perinatal care of the hospital of delivery.  This variable is coded as delivery in a 
Level III hospital (including RPCs as Level III hospitals) compared to delivery in a 
hospital with a lower designation and is assessed from birth certificate data or report of 
fetal death data, as applicable.  The following variables are included as confounders, with 
hypothesized associations with neonatal mortality and fetal mortality illustrated in the 
directed acyclic graph (DAG) in Figure 4.1: maternal age (continuous; birth certificate 
data, fetal death data), maternal race (non-Hispanic White, non-Hispanic Black, Hispanic 
and other; birth certificate data, fetal death data), initiation of prenatal care in the first 
trimester of pregnancy (yes, no; birth certificate data, fetal death data), method of 
delivery payment (private insurance, Medicaid, self-pay or other; birth certificate data), 
pre-pregnancy obesity status (obese [BMI≥30 kg/m2], overweight [25≤BMI<30 kg/m2, or 
normal/underweight [BMI<25 kg/m2]; birth certificate data [height and weight for birth 
and fetal death data are self-reported on the mother’s worksheet]), gestational diabetes 
(yes, no; birth certificate data, fetal death data), gestational hypertension or pre-eclampsia 
(yes, no; birth certificate data, fetal death data), surfactant replacement therapy during 
pregnancy (yes, no; birth certificate data), corticosteroid use during pregnancy (yes, no; 
birth certificate data), and assisted ventilation for newborn (yes, no; birth certificate data).   
 Gestational age at delivery was not included as a covariate because nearly all of 
the live births and fetal deaths included in this study were delivered preterm with over 
80% of all deliveries being early preterm (<32 weeks of gestation).  However, sensitivity 
analyses including gestational age as a continuous variable, a three-level categorical 
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variable (10-31 weeks, 32-36 weeks, ≥37 weeks), and a two-level categorical variable 
(10-31 weeks, ≥32 weeks) were conducted. 
 The DAG in Figure 4.1 indicates that fetal death is a common effect of several 
variables that confound the association between hospital level of perinatal care and 
neonatal mortality.  This, along with the fact that fetal deaths occur before neonatal 
deaths might occur (that is, fetal deaths are a competing risk for neonatal death), indicate 
that fetal death is a suitable candidate for consideration as a censoring event56. 
Population 
The analyses presented in this manuscript are restricted to fetal deaths and VLBW 
deliveries occurring in SC hospitals between 2004 and 2013.  Live births with a birth 
weight less than 500 grams have been removed from all analyses so that these results are 
comparable to other studies of perinatal regionalization and neonatal mortality, as these 
births are generally considered to be non-viable and would likely result in neonatal death 
no matter where they were delivered.  Furthermore, data are restricted to singleton 
deliveries without a birth defect indicated in birth certificate or fetal death data.  For 
multivariate analyses, only records without missing data on all covariates of interest were 
included (a total of 353 records with missing pre-pregnancy height or weight).  Figure 4.2 
depicts the number of observations excluded due to each criteria and the composition of 
the final analysis dataset (N=8,594). 
 A sensitivity analysis including deliveries weighing less than 500 grams was also 
conducted with neonatal deaths occurring to infants born weighing less than 500 grams 
included as censored outcomes. 
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Statistical Analysis 
Each characteristic hypothesized to be associated with fetal death and/or neonatal death 
was assessed by first examining the variable’s bivariate association with neonatal death 
and fetal death (where appropriate).  Bivariate associations were assessed for maternal 
age as a continuous variable using F tests while bivariate associations with categorical 
variables are assessed using χ2 tests. 
 Marginal structural modelling was used to assess the relative risk of neonatal 
mortality among VLBW infants delivered in Level III hospitals compared to VLBW 
infants born in hospitals with a lower perinatal care designation.  Marginal structural 
modelling estimates counterfactual contrasts using stabilized inverse probability 
weighting to create a pseudo-population to account for potential confounders by 
balancing those confounders across levels of the independent variable of primary interest 
(delivery in a Level III hospital for the present analysis).  Marginal structural models (see 
Hernan and Robins (2015)57) also account for censoring (in-hospital fetal deaths in this 
analysis) by including a component in the stabilized inverse probability weight that 
accounts for censoring by modeling the predictors of censored values.  The marginal 
structural model that accounted for censoring due to fetal deaths was compared to the 
marginal structural model that did not account for censoring, with the divisor of the 
relative risks indicating the impact of censoring.   
 For the marginal structural models used in this analysis, stabilized inverse 
probability weights (SWA) were developed based on the probability of being born in a 
Level III hospital both with and without accounting for the covariates of interest.  This 
derivation of weights is as depicted in equations (1), (2), and (3) below.  Equation (1) is a 
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logistic regression model with hospital level of care as the outcome variable and all of the 
covariates as independent variables.  The results from equation (1) were used to derive 
the denominator of the stabilized inverse probability weights.  Equation (2) is the null 
logistic regression model with hospital level of care as the outcome and no independent 
variables.  The results from equation (2) were used to derive the denominator of the 
stabilized inverse probability weights.  Equation (3) demonstrates how the results from 
equation (1) and equation (2) were used to calculate the confounding component of the 
stabilized inverse probability weights. 
Equation 1: 
𝑃(𝐴|𝐿) = 𝑃(𝑙𝑒𝑣𝑒𝑙3 = 1)
= 𝐿𝑜𝑔𝑖𝑡(𝛽0 + 𝛽1𝑎𝑔𝑒 + 𝛽2𝑟𝑎𝑐𝑒 + 𝛽3𝑝𝑟𝑒𝑛𝑎𝑡𝑎𝑙𝑐𝑎𝑟𝑒 + 𝛽4𝑜𝑏𝑒𝑠𝑖𝑡𝑦
+ 𝛽5𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠 + 𝛽6ℎ𝑦𝑝𝑡𝑒𝑟𝑡𝑒𝑛𝑠𝑖𝑜𝑛 + 𝛽7𝑑𝑒𝑙𝑖𝑣𝑒𝑟𝑦𝑝𝑚𝑡 + 𝛽8𝑠𝑢𝑟𝑓𝑎𝑐𝑡𝑎𝑛𝑡
+ 𝛽9𝑠𝑡𝑒𝑟𝑜𝑖𝑑𝑠 + 𝛽10𝑣𝑒𝑛𝑡𝑖𝑙𝑖𝑎𝑡𝑖𝑜𝑛),    
  where A = independent variable of primary interest 
   L = the set of additional independent variables 
Equation 2: 
𝑃(𝐴) = 𝑃(𝑙𝑒𝑣𝑒𝑙3 = 1) = 𝐿𝑜𝑔𝑖𝑡(𝛽0) 
Equation 3:  
𝑆𝑊𝐴 =
𝑃(𝐴)
𝑃(𝐴|𝐿)
,   𝑤ℎ𝑒𝑟𝑒 𝑙𝑒𝑣𝑒𝑙3 = 1 𝑜𝑟 
𝑆𝑊𝐴 =
1 − 𝑃(𝐴)
1 − 𝑃(𝐴|𝐿)
,   𝑤ℎ𝑒𝑟𝑒 𝑙𝑒𝑣𝑒𝑙3 = 0 
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 To account for censoring due to fetal deaths, a similar stabilized inverse-
probability weight balanced confounders across the censoring variable (fetal death).  
Equations (4), (5), and (6) demonstrate the calculation used for the censoring stabilized 
inverse-probability weight.  Equation (4) is a logistic regression model where fetal death 
(the censoring variable) is the outcome variable and the available covariates are included 
as independent variables.  Equation (5) is the null logistic regression model where fetal 
death is the outcome variable and no independent variables are included.  Similar to 
equation (3) above, equation (6) demonstrates how the results from equations (4) and (5) 
were used to calculate the censoring component of the stabilized inverse probability 
weights. 
Equation 4: 
𝑃(𝐶|𝐿) = 𝑃(𝑓𝑒𝑡𝑎𝑙𝑑𝑒𝑎𝑡ℎ = 1) = 𝐿𝑜𝑔𝑖𝑡(𝛽0 + 𝛽1𝑎𝑔𝑒 + 𝛽2𝑟𝑎𝑐𝑒 + 𝛽3𝑝𝑟𝑒𝑛𝑎𝑡𝑎𝑙𝑐𝑎𝑟𝑒 +
𝛽4𝑏𝑚𝑖 + 𝛽5𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠 + 𝛽6ℎ𝑦𝑝𝑡𝑒𝑟𝑡𝑒𝑛𝑠𝑖𝑜𝑛 + 𝛽7𝑙𝑒𝑣𝑒𝑙3), 
  where C = censoring variable 
Equation 5: 
𝑃(𝐶) = 𝑃(𝑓𝑒𝑡𝑎𝑙𝑑𝑒𝑎𝑡ℎ = 1) = 𝐿𝑜𝑔𝑖𝑡(𝛽0 + 𝛽1𝑙𝑒𝑣𝑒𝑙3) 
Equation 6: 
𝑆𝑊𝐶 =
𝑃(𝐶)
𝑃(𝐶|𝐿)
,   𝑤ℎ𝑒𝑟𝑒 𝑓𝑒𝑡𝑎𝑙𝑑𝑒𝑎𝑡ℎ = 1 𝑜𝑟 
𝑆𝑊𝐶 =
1 − 𝑃(𝐶)
1 − 𝑃(𝐶|𝐿)
,   𝑤ℎ𝑒𝑟𝑒 𝑓𝑒𝑡𝑎𝑙𝑑𝑒𝑎𝑡ℎ = 0 
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 Lastly, the final stabilized inverse probability weight was constructed using 
equation (7) by multiplying the confounding component weights and censoring 
component weight and then plugged into a log-binomial regression model to predict 
neonatal deaths from hospital level of perinatal care.  All stabilized inverse probability 
weights (including SWA, SWC, and SW) should have a mean at or near one as an 
indication of appropriate model fit and specification.  This criterion was checked for all 
stabilized inverse probability weights used in the analysis. 
Equation 7: 
𝑆𝑊 = 𝑆𝑊𝐴 ∗ 𝑆𝑊𝐶  
 A sensitivity analysis was conducted to examine the impact of SWA and SWC 
being constructed using the same predictors, which were restricted to variables available 
from both birth certificates and fetal death reports.  These results were compared to those 
obtained from the primary analysis to investigate any meaningful differences in 
interpretation.  Results from the marginal structural models were also compared to 
standard log-binomial regression results using neonatal mortality as the outcome 
(excluding fetal deaths) and also using perinatal mortality as the outcome (including in-
hospital fetal deaths and neonatal deaths). 
 All data management and analyses were conducted in SAS 9.3 (Cary, NC). The 
significance level was set at 5%. 
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Results 
Bivariate Results 
Table 4.1 displays the bivariate associations between characteristics of interest and 
neonatal mortality.  Among VLBW deliveries in Level I or Level II hospitals, 15% 
resulted in neonatal deaths, almost twice the percentage of neonatal death among VLBW 
deliveries in Level III hospitals (p<0.0001).  Furthermore, maternal age, gestational 
diabetes, gestational hypertension, use of antenatal steroids, surfactant replacement 
therapy for infants, and assisted ventilation for infants were also associated with 
increased neonatal mortality.  Many of these characteristics are related to very high risk 
pregnancies and deliveries. 
 Table 4.2 displays the bivariate associations between characteristics of interest 
and fetal mortality.  Several variables available on the birth certificate are not available 
on the report of fetal death certificate.  These variables include method of delivery 
payment, surfactant replacement therapy for infants, assisted ventilation for infants, and 
antenatal steroids.  Delivery in a Level III hospital, maternal age, maternal race/ethnicity, 
receipt of prenatal care in the first trimester, pre-pregnancy obesity status, gestational 
diabetes, and gestational hypertension were significantly associated with fetal mortality. 
Multivariate Results  
The results of the marginal structural models are displayed in Table 4.3.  Model 1 utilizes 
all of the available covariates to calculate the stabilized inverse probability weights.  
When using model 1 without accounting for censoring due to fetal deaths, VLBW infants 
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born in non-Level III hospitals had 1.62 (95% confidence interval [CI]: 1.36 – 1.93) 
times the risk of neonatal death compared to VLBW infants born in Level III hospitals.   
When using model 1 to account for censoring due to fetal deaths, VLBW infants 
born in non-Level III hospitals were again at increased risk of neonatal death.  
Specifically, VLBW infants born in non-Level III hospitals had 1.81 (95% CI: 1.52 – 
2.15) times the risk of neonatal death compared to VLBW infants born in Level III 
hospitals.  This indicates that accounting for censoring due to fetal deaths increases the 
relative risk of neonatal deaths among VLBW infant born in non-Level III hospitals by 
11.7%.   
 A sensitivity analysis in which only variables available on both the birth 
certificate and the report of fetal death certificate were included in the calculation of the 
stabilized inverse probability weights to ensure that the same covariates were used to 
create the weight for the independent variable of primary interest (birth in a Level III 
hospital) and the censoring variable (fetal death).  This was done because many of the 
variables that were excluded due to a lack of availability for fetal deaths were also 
significantly associated with neonatal mortality in the bivariate analyses.  Therefore, not 
accounting for these variables may substantially influence the association between 
hospital level of care and neonatal mortality.  However, as shown in Table 4.3, the 
direction and significance of the relative risks was found to be the same for model 2 as 
for model 1 with the results from model 2 indicating slightly greater risk of neonatal 
mortality for VLBW deliveries in non-Level III hospitals.  This suggests that including 
the additional variables available on the birth certificate but not the fetal death report to 
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calculate the weight for delivery hospital level of care does impact the results, but makes 
them slightly more conservative. 
 Table 4.4 presents the results from log-binomial regression models to estimate the 
adjusted relative risk of neonatal mortality and perinatal mortality (combining in-hospital 
fetal deaths and neonatal deaths into a single outcome).  Based on the log-binomial 
model, the risk of neonatal death among VLBW infants born in a non-Level III hospital is 
1.71 (95% CI: 1.44, 2.04) times the risk of neonatal death among VLBW infants born in a 
Level III hospital.  This estimated relative risk is similar, though slightly larger than the 
model 1 estimate for neonatal mortality using marginal structural modelling without 
accounting for censoring due to fetal deaths.  However, based on the log-binomial model, 
the risk of perinatal death among VLBW deliveries in a non-Level III hospital is 2.63 
(95% CI: 2.47, 2.79) times the risk of perinatal death among VLBW deliveries in Level 
III hospitals.  This estimated relative risk is substantially larger than the estimated risk of 
neonatal death from the marginal structural model accounting for censoring due to fetal 
deaths. 
 Sensitivity analyses including gestational age as a covariate produced relative risk 
estimates slightly greater in magnitude, but did not impact our interpretations or 
conclusions.  Results of these sensitivity analyses are available in Table 4.5 (continuous 
gestational age variable included), Table 4.6 (three-level categorical gestational age 
variable included), and Table 4.7 (two-level categorical gestational age variable 
included).  Additionally, a sensitivity analysis including all deliveries weighing less than 
500 grams resulted in similar relative risk estimates that also did not impact our 
interpretational or conclusions (Table 4.8).  
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Discussion 
This study estimates that VLBW deliveries occurring in non-Level III hospitals in SC 
have 81% greater risk of neonatal death when compared to VLBW deliveries occurring in 
Level III hospitals when accounting for pregnancies that ended in fetal death.  This 
indicates that the SC system of perinatal regionalization is working effectively and that 
every effort should be made to assure that high-risk pregnancies are receiving care at 
Level III hospitals at delivery.  Failing to account for pregnancies that did not reach live 
birth (i.e., fetal deaths as censoring events) may result in an underestimate of the true risk 
of neonatal death. 
The relative risk estimates for the association between delivery in a non-Level III 
hospital and neonatal death using marginal structural models but without accounting for 
censoring due to fetal mortality are in the same direction as those observed in other 
studies using neonatal death as an outcome8,9,11.  Although the magnitude of the 
association varies across studies10, the estimated relative risk of neonatal death found in 
our study without accounting for censoring due to fetal mortality is similar to that 
observed in other studies conducted in SC12,13.  However, the nearly 12% increase in the 
magnitude of the relative risk when accounting for censoring due to fetal deaths indicates 
that not accounting for fetal deaths as censored events when the event of interest is the 
neonatal death of live born infants produces an underestimate of the true impact of the 
effectiveness of perinatal regionalization.  Furthermore, the large difference in the 
magnitude of the relative risk estimates between considering fetal deaths as part of the 
perinatal death outcome variable (RR=2.63 from the log-binomial regression models) and 
considering fetal deaths as censored observations for an outcome of neonatal death 
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(RR=1.81 from the marginal structural models) may indicate that neonatal death and in-
hospital fetal death have different magnitudes of risk given the level of prenatal care of 
the delivering hospital. 
It could be that VLBW infants delivered in non-Level III hospitals are 
systematically different from those delivered in Level III hospitals with respect to risk 
status.  For example, the highest-risk pregnancies resulting in VLBW deliveries may be 
more likely to be transferred to a Level III hospital prior to delivery, making Level III 
deliveries systematically more high-risk.  Alternatively, VLBW deliveries at non-Level 
III hospitals may be more likely to be the result of emergency situations that prevent the 
safe transport to a Level III hospital for delivery, making non-Level III deliveries 
systematically more high-risk.  Some studies have used instrumental variable analysis to 
account for this unmeasured difference in risk status11,27.  This paper accounts for 
potential differences in the risk status of deliveries at hospitals with different levels of 
perinatal care by restricting analyses to deliveries without reported congenital anomalies 
and by adjusting for treatments associated with high-risk pregnancies, including assisted 
ventilation for the infant, surfactant replacement therapy for the infant, and antenatal 
steroid use. 
This study is subject to several limitations.  First, as with any observational study, 
there may be uncontrolled confounding that could change the nature of the observed 
association if appropriately considered.  Only variables included on birth certificates, 
fetal death reports, death certificates, and hospital discharge data were available. Since 
neonatal death is a relatively rare outcome, we are limited by the number of variables that 
can be included in the model without resulting in combinations of covariate levels with 
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zero observations in the dataset.  An additional limitation is that most of the variables 
used in this study are based on vital records data, primarily from birth certificates and 
reports of fetal death.  Data from birth certificates in SC have been shown to have low 
sensitivity for some variables when compared to medical records; however, most of the 
variables used in this study have been shown to have substantial or high sensitivity58.  
This study assumes that the quality of data on report of fetal death certificates is similar 
to that of corresponding variables from birth certificates. 
South Carolina is a state with a regulated perinatal regionalization system that 
defines the requirements for designation at the different perinatal levels of care and 
licenses hospitals to function within the parameters of their perinatal level of care 
designation.  This makes the policy and practice environment with respect to the delivery 
of VLBW infants within SC different than many other states14,19.  Examining the 
difference in perinatal outcomes among high-risk deliveries among different levels of 
perinatal care in a state with a strong perinatal regionalization system is essential to 
helping to inform whether perinatal regionalization systems are effectively preventing 
poor birth outcomes such as neonatal mortality. 
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Table 4.1: Bivariate associations between delivery characteristics and neonatal mortality 
among live births (n=6,726) occurring in SC hospitals, 2004-2013. 
 
Characteristic 
No Neonatal Death Neonatal Death 
p-
value* Mean/ 
Numbe
r 
Standard 
Deviation
/ 
Percent 
Mean/ 
Numbe
r 
Standard 
Deviation
/ 
Percent 
Maternal Age (years)^ 26.20 6.33 25.51 6.52 0.01 
Delivered in a Level III Facility 
        No 868 85.00 153 15.00 <0.000
1    Yes 5,258 92.16 447 7.84 
Maternal Race/Ethnicity 
        Non-Hispanic White 2,087 90.35 223 9.65 
0.30    Non-Hispanic Black 3,615 91.43 339 8.57 
   Hispanic/Other 424 91.77 38 8.23 
Prenatal Care in the First Trimester 
       No 2,048 91.55 189 8.45 
0.34 
   Yes 4,078 90.84 411 9.16 
Method of Delivery Payment 
        Medicaid 3,741 91.36 354 8.64 
0.50    Private Insurance 1,599 90.90 160 9.10 
   Self-pay/Other 786 91.14 86 9.86 
Body Mass Index Classification 
        Underweight/Normal Weight 2,469 91.01 244 8.99 
0.96    Overweight 1,404 90.99 139 9.01 
   Obese 2,253 91.21 217 9.79 
Gestational Diabetes 
        No 5,856 90.83 591 9.17 
0.0007 
   Yes 270 96.77 9 3.23 
Gestational Hypertension 
        No 4,952 89.71 568 10.29 <0.000
1   Yes 1,174 97.35 32 2.65 
Surfactant Replacement Therapy 
        No  4,699 90.52 492 9.48 
0.003 
   Yes 1,427 92.96 108 7.04 
Antenatal Steroids 
        No 5,081 90.46 536 9.54 <0.000
1    Yes 1,045 94.23 64 5.77 
Assisted Ventilation for Infant 
        No 3,520 90.44 372 9.56 
0.03 
   Yes 2,606 91.95 228 8.05 
Total 6,126   600     
*P-value for the continuous maternal age variable comes from the F test. 
**P-values for categorical variables come from Chi-Squared tests. 
^Indicates a continuous variable 
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Table 4.2: Bivariate associations between delivery characteristics and fetal deaths 
(n=8,594) occurring in SC hospitals, 2004-2013. 
 
Characteristic 
No Fetal Death Fetal Death 
p-value* Mean/ 
Numbe
r 
Standard 
Deviation
/ 
Percent 
Mean/ 
Numbe
r 
Standard 
Deviation
/ 
Percent 
Maternal Age (years)^ 26.13 6.35 26.65 6.51 0.0009 
Delivered in a Level III Facility 
        No 1,021 51.05 979 48.95 
<0.0001 
   Yes 5,705 86.52 889 13.48 
Maternal Race/Ethnicity 
        Non-Hispanic White 2,310 75.91 733 24.09 
0.0001    Non-Hispanic Black 3,954 79.88 996 20.12 
   Hispanic/Other 462 76.87 139 23.13 
Prenatal Care in the First Trimester 
       No 2,237 82.15 486 17.85 
<0.0001 
   Yes 4,489 76.46 1,382 23.54 
Method of Delivery Payment 
        Medicaid         
     Private Insurance         
   Self-pay/Other         
Body Mass Index Classification 
        Underweight/Normal Weight 2,713 80.03 677 19.97 
0.006    Overweight 1,543 77.27 454 22.73 
   Obese 2,470 77.02 737 22.98 
Gestational Diabetes 
        No 6,447 78.44 1,772 21.56 
0.06 
   Yes 279 74.40 96 25.60 
Gestational Hypertension 
        No 5,520 76.00 1,723 24.00 
<0.0001 
  Yes 1,206 90.61 125 9.39 
Surfactant Replacement Therapy 
        No          
  
   Yes         
Antenatal Steroids 
        No         
  
   Yes         
Assisted Ventilation for Infant 
        No         
  
   Yes         
Total 6,726   1,868     
*P-value for the continuous maternal age variable comes from the F test. 
**P-values for categorical variables come from Chi-Squared tests. 
^Indicates a continuous variable. 
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Table 4.3: Relative risk of neonatal death for delivery in a non-Level III hospital, 
compared to deliveries in a Level III hospital, from marginal-structural models with 
and without consideration of censoring due to fetal deaths. 
 
Marginal-Structural Model ARR 95% CI 
Live births only, no censoring by fetal deaths -- Model 1* 1.62 (1.36, 1.93) 
All in-hospital deliveries, fetal deaths analyzed as censored -- Model 1* 1.81 (1.52, 2.15) 
Live births only, no censoring by fetal deaths -- Model 2** 1.72 (1.45, 2.05) 
All in-hospital deliveries, fetal deaths analyzed as censored -- Model 2** 1.88 (1.55, 2.28) 
*Model 1 adjusts for the following variables for live births: maternal age, maternal race, first trimester 
entry into prenatal care, pre-pregnancy body mass index, gestational hypertension, gestational diabetes, 
method of delivery payment, surfactant replacement therapy, antenatal steroids, and assisted ventilation 
for infant. 
If fetal deaths are included as censored observations, fetal deaths are adjusted for maternal age, 
maternal race, first trimester entry into prenatal care, pre-pregnancy body mass index, gestational 
hypertension, and gestational diabetes. 
**Model 2 adjusts for the following variables for live births and fetal deaths (if fetal deaths are 
included as censored observations): maternal age, maternal race, first trimester entry into prenatal care, 
pre-pregnancy body mass index, gestational hypertension, and gestational diabetes. 
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Table 4.4: Relative risk of neonatal and 
perinatal death for delivery in a non-Level 
III hospital, compared to delivery in a 
Level III hospital, from log-binomial 
regression. 
 
Outcome Variable ARR 95% CI 
Neonatal death* 1.71 (1.44, 2.04) 
Perinatal death** 2.63 (2.47, 2.79) 
*Neonatal death model adjusts for the 
following variables for live births: 
maternal age, maternal race, first trimester 
entry into prenatal care, pre-pregnancy 
body mass index, gestational 
hypertension, gestational diabetes, 
method of delivery payment, surfactant 
replacement therapy, antenatal steroids, 
and assisted ventilation for infant. 
**Perinatal death model adjusts for the 
following variables for live births and 
fetal deaths (if fetal deaths are included as 
censored observations): maternal age, 
maternal race, first trimester entry into 
prenatal care, pre-pregnancy body mass 
index, gestational hypertension, and 
gestational diabetes. 
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Table 4.5: Relative risk of neonatal death for delivery in a non-Level III hospital, 
compared to deliveries in a Level III hospital, from marginal-structural models with 
and without consideration of censoring due to fetal deaths.  Sensitivity analysis 
including continuous gestational age variable. 
 
Marginal-Structural Model ARR 95% CI 
Live births only, no censoring by fetal deaths -- Model 1* 1.89 (1.59, 2.23) 
All in-hospital deliveries, fetal deaths analyzed as censored -- Model 1* 2.12 (1.81, 2.50) 
Live births only, no censoring by fetal deaths -- Model 2** 1.97 (1.66, 2.33) 
All in-hospital deliveries, fetal deaths analyzed as censored -- Model 2** 2.35 (1.97, 2.81) 
*Model 1 adjusts for the following variables for live births: maternal age, maternal race, first trimester 
entry into prenatal care, pre-pregnancy body mass index, gestational hypertension, gestational 
diabetes, method of delivery payment, surfactant replacement therapy, antenatal steroids, assisted 
ventilation for infant, and gestational age. 
If fetal deaths are included as censored observations, fetal deaths are adjusted for maternal age, 
maternal race, first trimester entry into prenatal care, pre-pregnancy body mass index, gestational 
hypertension, gestational diabetes, and gestational age. 
**Model 2 adjusts for the following variables for live births and fetal deaths (if fetal deaths are 
included as censored observations): maternal age, maternal race, first trimester entry into prenatal care, 
pre-pregnancy body mass index, gestational hypertension, gestational diabetes, and gestational age. 
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Table 4.6: Relative risk of neonatal death for delivery in a non-Level III hospital, 
compared to deliveries in a Level III hospital, from marginal-structural models with 
and without consideration of censoring due to fetal deaths.  Sensitivity analysis 
including a three-category gestational age variable (10-31 weeks, 32-36 weeks, 37+ 
weeks). 
 
Marginal-Structural Model ARR 95% CI 
Live births only, no censoring by fetal deaths -- Model 1* 1.81 (1.52, 2.15) 
All in-hospital deliveries, fetal deaths analyzed as censored -- Model 1* 2.02 (1.73, 2.35) 
Live births only, no censoring by fetal deaths -- Model 2** 1.90 (1.60, 2.25) 
All in-hospital deliveries, fetal deaths analyzed as censored -- Model 2** 2.18 (1.85, 2.58) 
*Model 1 adjusts for the following variables for live births: maternal age, maternal race, first trimester 
entry into prenatal care, pre-pregnancy body mass index, gestational hypertension, gestational 
diabetes, method of delivery payment, surfactant replacement therapy, antenatal steroids, assisted 
ventilation for infant, and gestational age. 
If fetal deaths are included as censored observations, fetal deaths are adjusted for maternal age, 
maternal race, first trimester entry into prenatal care, pre-pregnancy body mass index, gestational 
hypertension, gestational diabetes, and gestational age. 
**Model 2 adjusts for the following variables for live births and fetal deaths (if fetal deaths are 
included as censored observations): maternal age, maternal race, first trimester entry into prenatal care, 
pre-pregnancy body mass index, gestational hypertension, gestational diabetes, and gestational age. 
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Table 4.7: Relative risk of neonatal death for delivery in a non-Level III hospital, 
compared to deliveries in a Level III hospital, from marginal-structural models with 
and without consideration of censoring due to fetal deaths.  Sensitivity analysis 
including a two-category gestational age variable (10-31 weeks, 32+ weeks). 
 
Marginal-Structural Model ARR 95% CI 
Live births only, no censoring by fetal deaths -- Model 1* 1.81 (1.52, 2.15) 
All in-hospital deliveries, fetal deaths analyzed as censored -- Model 1* 2.05 (1.76, 2.39) 
Live births only, no censoring by fetal deaths -- Model 2** 1.89 (1.60, 2.25) 
All in-hospital deliveries, fetal deaths analyzed as censored -- Model 2** 2.22 (1.88, 2.63) 
*Model 1 adjusts for the following variables for live births: maternal age, maternal race, first trimester 
entry into prenatal care, pre-pregnancy body mass index, gestational hypertension, gestational 
diabetes, method of delivery payment, surfactant replacement therapy, antenatal steroids, assisted 
ventilation for infant, and gestational age. 
If fetal deaths are included as censored observations, fetal deaths are adjusted for maternal age, 
maternal race, first trimester entry into prenatal care, pre-pregnancy body mass index, gestational 
hypertension, gestational diabetes, and gestational age. 
**Model 2 adjusts for the following variables for live births and fetal deaths (if fetal deaths are 
included as censored observations): maternal age, maternal race, first trimester entry into prenatal care, 
pre-pregnancy body mass index, gestational hypertension, gestational diabetes, and gestational age. 
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Table 4.8: Relative risk of neonatal death for delivery in a non-Level III hospital, 
compared to deliveries in a Level III hospital, from marginal-structural models with 
and without consideration of censoring due to fetal deaths.  Sensitivity analysis 
including live births <500 grams, with neonatal deaths among live-born infants 
weighing <500 grams censored. 
 
Marginal-Structural Model ARR 95% CI 
Live births only, no censoring by fetal deaths -- Model 1* 1.56 (1.31, 1.87) 
All in-hospital deliveries, fetal deaths analyzed as censored -- Model 1* 1.73 (1.46, 2.05) 
Live births only, no censoring by fetal deaths -- Model 2** 1.68 (1.41, 2.00) 
All in-hospital deliveries, fetal deaths analyzed as censored -- Model 2** 1.79 (1.48, 2.18) 
*Model 1 adjusts for the following variables for live births: maternal age, maternal race, first trimester 
entry into prenatal care, pre-pregnancy body mass index, gestational hypertension, gestational 
diabetes, method of delivery payment, surfactant replacement therapy, antenatal steroids, and assisted 
ventilation for infant. 
If fetal deaths are included as censored observations, fetal deaths are adjusted for maternal age, 
maternal race, first trimester entry into prenatal care, pre-pregnancy body mass index, gestational 
hypertension, and gestational diabetes. 
**Model 2 adjusts for the following variables for live births and fetal deaths (if fetal deaths are 
included as censored observations): maternal age, maternal race, first trimester entry into prenatal care, 
pre-pregnancy body mass index, gestational hypertension, and gestational diabetes. 
 
 
 
 
  
  
 
4
5
 
  
 
Figure 4.1: Directed acyclic graph (DAG) for the relationship between level of perinatal care for the hospital of delivery and neonatal 
mortality (outcome of interest) and fetal mortality (censoring event). 
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Figure 4.2: Sample size and exclusions for final set of deliveries included in analyses. 
16,062 live births <1,500g or fetal deaths 
(10,820 live births, of which 1,664 were neonatal 
deaths, and 5,242 fetal deaths) 
1,154 live births <500g 
14,908 live births 500-1,500g or fetal deaths 
(9,666 live births, of which 868 were neonatal 
deaths, and 5,242 fetal deaths) 
1,188 fetal deaths and 526 live 
births occurring outside a SC 
hospital 
13,194 in-hospital live births 500-1,500g or fetal deaths 
(9,140 live births, of which 824 were neonatal deaths, 
and 4,054 fetal deaths) 
2,472 twins or higher order 
multiples 
10,722 in-hospital live births 500-1,500g or fetal deaths 
(7,030 live births, of which 654 were neonatal deaths, 
and 3,692 fetal deaths) 
1,775 reported congenital 
anomalies 
8,947 in-hospital live births 500-1,500g or fetal deaths 
(6,933 live births, of which 624 were neonatal deaths, 
and 2,014 fetal deaths) 
353 with missing values for 
pre-pregnancy BMI 
8,594 in-hospital live births 500-1,500g or fetal deaths 
(6,726 live births, of which 600 were neonatal deaths, 
and 1,868 fetal deaths) 
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CHAPTER 5 
 
TESTING STATISTICAL MODELS FOR ANALYZING SIMULATED 
HIGHLY SKEWED OUTCOMES2
                                                          
2 Smith M.G., Geraci M., Fleischer N., Hale N., Hardin J. To be submitted to 
Computational Statistics and Data Analysis. 
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The purpose of this chapter is to examine the performance of several statistical regression 
models when analyzing an outcome that is highly skewed. 
 
Introduction 
Reducing the length of a patient’s hospital stay to the minimum appropriate duration has 
long been a goal for clinicians, hospitals, and insurance companies.  The release of the 
Institute for Healthcare Improvement’s Triple Aim to improve health, improve care, and 
reduce cost in 2008 has served to further crystalize focus on health services outcomes 
including hospital length of stay (HLS)59.  This focus has resulted in hospital systems and 
insurance providers increasing efforts to ensure that quality care is provided to patients in 
an effort to efficiently aid in their recovery to prevent costly additional days of 
admission, while minimizing subsequent re-admissions. 
 HLS data generally have several defining characteristics.  The data are usually 
highly skewed with a peak early in the distribution and a long tail.  A hospital stay can 
end in discharge, or can be censored by death or transfer to another facility.  In fact, there 
is potential for a wide range in the percentage of observations that are censored when 
hospital discharge is the outcome of interest.  This paper will focus on HLS among high-
risk infants immediately postpartum.  This population generally has two main censoring 
events: hospital stays that end in a transfer and hospital stays that end in death.  Among 
very low birth weight births occurring in South Carolina from 2004-2013, roughly 4% of 
hospital stays ended in a transfer without readmission in the state and 11% ended in in-
hospital infant death (based on analysis done by authors).  Furthermore, while deaths 
occur across the HLS distribution, many of them occur in the first few days of stay. 
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A variety of statistical approaches have been used to analyze HLS as an outcome 
of interest.  These approaches analyze HLS as a continuous outcome, a count outcome, or 
a survival outcome.  In particular, linear regression with a log-transformed continuous 
HLS variable has been used to assess the impact of a variety of characteristics associated 
with HLS36–39, although most of the studies using this method were published prior to 
2001.  Studies have also considered HLS to be a count outcome and have thus applied 
Poisson regression and negative binomial regression models in these analyses40–43.  A few 
studies have used survival analysis to examine HLS as an outcome using both semi-
parametric (Cox proportional hazards regression)44–46 and parametric (accelerated failure 
time regression) models45,47,48.  Some recent studies used quantile regression models for 
which the HLS was considered a continuous variable49–52, while others have applied 
count data to quantile regression models 53.  Finally, at least one study used Laplace 
regression to model hospital HLS as a survival outcome for quantiles of interest54. 
Statistical Models  
In this paper, data with a variety of potential HLS distributions were generated, and 
analyses were conducted considering HLS as continuous outcome, a count outcome, and 
a survival outcome.  The simulated hospital HLS distributions were varied by sample size 
and percentage of censored data.  Each distribution was simulated and analyzed with each 
method 1,000 times, with results evaluated based on the mean of the parameter estimates 
of interest across analyses of simulated datasets.  Additionally, the 5th and 95th centiles of 
the parameter estimates were considered to aid in assessing the accuracy of the analysis 
method for estimation.  Each analysis method was evaluated based on the proximity of 
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the parameter estimates to the true parameter value and whether the true parameter value 
fell within the 5th and 95th centiles of the parameter estimates. 
 Though HLS data are generally no longer analyzed as a continuous variable, two 
models for continuous outcomes were explored for the sake of performance comparison:  
ordinary least squares (OLS) linear regression with a log-transformed outcome to account 
for the skewed distribution, and quantile regression with a log-transformed outcome.  For 
simplicity, the following quantile regression model was used to assess the median: 
𝑄𝑦𝑖|𝑥𝑖(𝜏) = 𝑥𝑖
′𝛽𝜏,   𝑤ℎ𝑒𝑟𝑒 𝜏 = 0.5. 
Additional details about quantile regression are available elsewhere60. 
A HLS variable may also be considered a count outcome: the number of days 
until a discharge.  Using simulated HLS data, our research compared the performance of 
count outcome models to each other and to the performance of the continuous outcome 
models.  The count outcome models that were considered in our simulation study 
included Poisson regression, negative binomial regression, and a quantile regression 
model extended for count data.  While Poisson regression is often used to model count 
outcomes, negative binomial regression includes one additional parameter to more 
effectively measure highly skewed distributions.  Because many of the outcomes values 
in count data are tied (e.g., many observations with one day or two day HLS values), the 
outcome is modified slightly for quantile regression using a process known as jittering.  
Jittering adds a small uniform random decimal value to the outcome to greatly reduce or 
eliminate ties.  After a jittering process was applied to the outcome, the quantile model 
referenced above was fitted. 
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 Finally, a HLS may be considered a survival outcome: the amount of time 
(usually in days) until hospital discharge.  Considering HLS as a survival outcome may 
be especially attractive if there is a substantial amount of censoring in the outcome (e.g., 
due to death and/or transfer, as mentioned above).  In the event of censoring, the outcome 
under study is  
𝑌 = min(𝑇, 𝐶), 
where T is the true time until hospital discharge (unknown in the event of censoring) and 
C is the time until the observation is censored.  Given this outcome, the effect of the 
predictor of interest on Y was estimated using (1) an accelerated failure time (AFT) 
model with the correct distribution of T specified, (2) an AFT model with the incorrect 
distribution of T specified, and (3) a Laplace regression model.  The Cox proportional 
hazards model was not included because it models hazard rather than survival. 
 Laplace regression is an extension of quantile regression to censored data.  
Laplace regression uses the quantile regression model given above, but assumes that the 
error term follows an asymmetric Laplace distribution.  Therefore,  
𝑄𝑦𝑖|𝑥𝑖(𝜏) = 𝑥𝑖
′𝛽𝜏 + 𝜀𝑖𝜏𝑢𝑖, where  
𝑢~𝜏(1 − 𝜏)𝑒𝐼𝑢≤0−𝜏𝑢. 
Additional details of Laplace regression are available elsewhere61.  The results from the 
survival models were compared to those from the count outcome models and the 
continuous outcome models.   
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Simulation 
Highly skewed data to approximate a HLS distribution were simulated from a log-normal 
distribution with μ = 1 – 1xi and σ2 = 1.3.  Censoring data were also simulated from a 
log-normal distribution with varying values of μ to produce different amounts of 
censoring.  To produce data with roughly 8% of the observations censored, μ = 4 and σ2 
= 1.5 were specified; to produce data with roughly 20% of the observations censored, μ = 
2.75 and σ2 = 1.5 were specified; and to produce data with roughly 50% of the 
observations censored, μ = 1 and σ2 = 1.5 were specified.  Each dataset was simulated to 
have 100, 1,000, and 10,000 observations and was replicated 1,000 times.  Each 
replicated dataset was analyzed with the statistical models mentioned above for 
continuous outcomes, count outcomes, and survival outcomes.  Censored observations 
were removed from analyses for continuous and count outcomes.  Data simulation and 
analyses were done using Stata 13 (College Station, TX) and data management was done 
using SAS 9.3 (Cary, NC). 
Tables 5.1, 5.2, and 5.3 provide the results from each analysis when 8% of the 
data are censored, 20% of the data are censored, and 50% of the data are censored, 
respectively.  Analyzing the highly skewed outcome as a continuous variable with log-
transformed linear and quantile regression at the median produced consistent 
underestimates of the true associations; the underestimate increased in magnitude as the 
percent of censored observations increased.  When analyzing the outcome as a count 
variable using Poisson regression and negative binomial regression, the β1 parameter 
estimate was consistently underestimated, with the magnitude of the underestimation also 
increasing as the percentage of censored observations increased.  Poisson and negative 
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binomial regression overestimated the β0 parameter when roughly 8% and 20% of the 
observations were censored and underestimated the β0 parameter when roughly 50% of 
the observations were censored.  Quantile regression for the median when the outcome 
was jittered consistently underestimated the β0 parameter for all sample sizes and 
censoring percentages and slightly underestimated the β1 parameter when the censoring 
percentage was low.  The magnitude of the underestimate of the β1 parameter increased 
substantially as the censoring percentage increased. 
  Parametric AFT models consistently correctly estimated the β1 parameter 
regardless of sample size or censoring percentage.  However, the exponential AFT 
model, which did not correctly specify the underlying distribution giving rise to the data, 
consistently overestimated the β0 parameter.  As expected, the log-normal AFT model, 
which correctly specified the underlying distribution, performed better than any other 
analysis model and correctly estimated β0 and β1 across sample sizes and censoring 
percentages.  Laplace regression performed nearly as well as the log-normal AFT model, 
correctly estimating β0 and β1 consistently but with slightly more variability in its 
estimates than the log-normal AFT model.  This slightly increased variability (compared 
to the log-normal AFT model results) decreased as sample sizes increased.  For example, 
when 20% of the observations were censored, the standard deviation of the log-normal 
AFT estimates of β0 were as follows: 0.13 when N=100, 0.04 when N=1,000, and 0.012 
when N=10,000; compared to the following standard deviations of the Laplace estimates 
of β0: 0.15 when N=100, 0.05 when N=1,000, and 0.014 when N=10,000.  Similarly, 
when 20% of the observations were censored, the standard deviation of the log-normal 
AFT estimates of β1 were as follows: 0.12 when N=100, 0.04 when N=1,000, and 0.012 
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when N=10,000; compared to the following standard deviations of the Laplace estimates 
of β1: 0.15 when N=100, 0.05 when N=1,000, and 0.015 when N=10,000. 
When the data arise from a log-normal distribution, analyzing the data with a log-
normal AFT model results in accurate parameter estimation.  However, when the 
exponential AFT model is used, miss-specifying the underlying distribution of the data, 
biased parameter estimates are observed, especially for the β0 parameter.  In comparison, 
using a Laplace model does not require that the correct underlying distribution of the data 
be specified and is, therefore, not subject to the potential miss-specified distribution bias 
observed with AFT models.  Therefore, in practice, if the distribution giving rise to the 
data is unknown, analyzing the data with Laplace regression is recommended.  The 
modest loss of precision described above is preferable to the potential bias introduced by 
incorrectly specifying the underlying distribution.   
Example 
In this section we present an example of the methods above used to analyze HLS data for 
very low birth weight newborns in SC from 2004-2013.  Data are from linked birth 
certificate and hospital discharge uniform billing databases.  For these analyses one HLS 
outcome measure is used for each infant by summing the HLS values from successive 
hospital transfers, if applicable.  The primary interest in this example is whether neonatal 
intensive care unit (NICU) admission is significantly associated with HLS.  
 The following regression models were used to investigate the association between 
NICU admission and HLS: log-transformed linear regression, log-transformed quantile 
regression modeling the median, Poisson regression, negative binomial regression, 
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quantile regression with a jittered HLS outcome modeling the median, Cox proportional 
hazards regression, accelerated failure time regression assuming a log-normal 
distribution, accelerated failure time assuming an exponential distribution, and Laplace 
regression modeling the median.  Each model is restricted to singleton live births with a 
birth weight from 500-1,499g and no birth defects reported on the birth certificate.  Each 
regression model was adjusted for maternal age (<18, 18-24, 25-34, ≥35), maternal race 
(non-Hispanic white, non-Hispanic black, or other), prenatal initiation in the first 
trimester of pregnancy (yes or no), method of delivery payment (private insurance, 
Medicaid, or other), and obesity status (underweight/normal weight, overweight, obese).  
The purpose of this analysis is not to assess the association between NICU admission and 
HLS, but rather to demonstrate the variation in results when different methods are used to 
analyze real world birth outcome data.  Therefore, these covariates may not be the most 
appropriate characteristics to include to critically assess the relationship.  Results in this 
section should be considered for example purposes only and should be interpreted with 
caution.   
 There were a total of 7,252 infants that met the inclusion criteria, of which 14.3% 
had a censored HLS outcome.  The distribution of the HLS variable is displayed in Figure 
5.1.  Of the infants included, 6,185 were admitted to a NICU and 1,067 were not admitted 
to a NICU.  Infants who were admitted to a NICU and were not censored had a mean 
HLS of 58.15 days (median=51 days) while infants who were not admitted to a NICU 
and were not censored had a mean HLS of 37.78 days (median=33 days).   
Table 5.4 displays the estimated adjusted association between NICU admission 
and HLS using each analysis method.  Log-transformed linear and quantile regression 
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estimate an intercept of 3.06 and 3.45 days of hospital stay, respectively, with 0.76 and 
0.43 day median increases in HLS for NICU admission.  Poisson and negative binomial 
regression models both resulted in a 3.6 day HLS intercept with a median of 0.43 day 
increase in HLS for NICU admission.  Log-normal AFT and exponential AFT models 
resulted in an intercept of 3.12 and 3.68 days of HLS intercepts and 0.77 and 0.45 days 
median increases in HLS for NICU admission.  All of these estimates are substantially 
lower than the unadjusted median HLS for NICU and non-NICU admitted VLBW 
infants.  The results from the jittered quantile regression model estimated the intercept at 
30.32 days HLS with an increased median HLS of 17.88 days for NICU admission, a 
much more reasonable result given the unadjusted median HLS values presented above.  
Based on the results explored in the Simulation section above, the results from the 
Laplace regression model are the most appropriate to use for inference because the 
distribution that produced the HLS data in this example is unknown.  Furthermore, the 
results from the Laplace regression fit well with the unadjusted HLS data by NICU 
admission status discussed above.  Therefore, we conclude that being admitted to a NICU 
increases the median HLS by 18 days among this study population. 
Conclusions 
Analyzing highly skewed data such as HLS as a continuous or count outcome can 
produce biased results.  Analyzing the highly skewed data simulated for this study as a 
survival outcome produced the most consistently accurate results.  If the correct 
distribution giving rise to the data is specified then AFT models work quite well.  
However, if the underlying distribution is mis-specified the estimated β0 parameter is 
consistently overestimated.  Laplace regression correctly estimated all parameters and is 
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recommended for analyzing highly skewed outcomes unless the underlying distribution 
of the data is known with a high degree of confidence. 
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Table 5.1: Summary of analysis results with approximately 8% of the 
observations censored.  1,000 replications with β0=1 and β1=-1. 
 
Sample size=100; 8.00% censored 
Treatment of Outcome Variable 
Mean 
β0 
(5% of 
estimates, 
95% of 
estimates) 
Mean 
β1 
(5% of 
estimates, 
95% of 
estimates) 
Analyzed as a continuous outcome 
    
   Log-transformed linear regression 0.90 (0.72, 1.10) -0.92 (-1.11, -0.73) 
   Log-transformed median 
regression 0.91 (0.69, 1.15) -0.93 (-1.17, -0.73) 
Analyzed as a count outcome 
       Poisson regression 1.47 (1.21, 1.74) -0.85 (-1.21, -0.58) 
   Negative binomial regression 1.47 (1.23, 1.73) -0.89 (-1.12, -0.64) 
   Median regression with jittered 
outcome 0.66 (0.43, 0.89) -0.93 (-1.17, -0.68) 
Analyzed as a survival outcome 
       Accelerated failure time model 
(lognormal) 1.00 (0.81, 1.20) -1.00 (-1.20, -0.81) 
   Accelerated failure time model 
(exponential) 1.59 (1.34, 1.84) -0.97 (-1.21, -0.72) 
   Median survival model (Laplace 
regression) 1.00 (0.78, 1.23) -1.00 (-1.23, -0.75) 
Sample size=1,000; 7.98% censored 
Treatment of Outcome Variable 
Mean 
β0 
(5% of 
estimates, 
95% of 
estimates) 
Mean 
β1 
(5% of 
estimates, 
95% of 
estimates) 
Analyzed as a continuous outcome 
    
   Log-transformed linear regression 0.90 (0.83, 0.96) -0.92 (-0.99, -0.86) 
   Log-transformed median 
regression 0.91 (0.83, 0.98) -0.93 (-1.00, -0.85) 
Analyzed as a count outcome 
       Poisson regression 1.49 (1.41, 1.58) -0.85 (-0.97, -0.75) 
   Negative binomial regression 1.48 (1.41, 1.56) -0.88 (-0.96, -0.80) 
   Median regression with jittered 
outcome 0.66 (0.58, 0.73) -0.93 (-1.00, -0.85) 
Analyzed as a survival outcome 
       Accelerated failure time model 
(lognormal) 1.00 (0.94, 1.06) -1.00 (-1.06, -0.94) 
   Accelerated failure time model 
(exponential) 1.60 (1.52, 1.68) -0.97 (-1.05, -0.89) 
 59 
 
   Median survival model (Laplace 
regression) 1.00 (0.92, 1.07) -1.00 (-1.07, -0.92) 
Sample size=10,000; 7.97% censored 
Treatment of Outcome Variable 
Mean 
β0 
(5% of 
estimates, 
95% of 
estimates) 
Mean 
β1 
(5% of 
estimates, 
95% of 
estimates) 
Analyzed as a continuous outcome 
    
   Log-transformed linear regression 0.90 (0.88, 0.92) -0.92 (-0.94, -0.90) 
   Log-transformed median 
regression 0.91 (0.88, 0.93) -0.93 (-0.95, -0.90) 
Analyzed as a count outcome 
       Poisson regression 1.49 (1.47, 1.52) -0.85 (-0.89, -0.81) 
   Negative binomial regression 1.48 (1.46, 1.51) -0.88 (-0.91, -0.86) 
   Median regression with jittered 
outcome 0.66 (0.63, 0.68) -0.93 (-0.95, -0.90) 
Analyzed as a survival outcome 
       Accelerated failure time model 
(lognormal) 1.00 (0.98, 1.02) -1.00 (-1.02, -0.98) 
   Accelerated failure time model 
(exponential) 1.60 (1.58, 1.62) -0.97 (-1.00, -0.94) 
   Median survival model (Laplace 
regression) 1.00 (0.97, 1.02) -1.00 (-1.02, -0.97) 
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Table 5.2: Summary of analysis results with approximately 20% of the 
observations censored.  1,000 replications with β0=1 and β1=-1. 
 
Sample size=100; 20.52% censored 
Treatment of Outcome Variable 
Mean 
β0 
(5% of 
estimates, 
95% of 
estimates) 
Mean 
β1 
(5% of 
estimates, 
95% of 
estimates) 
Analyzed as a continuous outcome 
    
   Log-transformed linear regression 0.76 (0.57, 0.96) -0.86 (-1.07, -0.65) 
   Log-transformed median 
regression 0.77 (0.52 1.02) -0.86 (-1.11, -0.59) 
Analyzed as a count outcome 
       Poisson regression 1.28 (1.03, 1.54) -0.78 (-1.10, -0.51) 
   Negative binomial regression 1.28 (1.04, 1.54) -0.91 (-1.07, -0.57) 
   Median regression with jittered 
outcome 0.51 (0.27, 0.77) -0.86 (-1.14, -0.58) 
Analyzed as a survival outcome 
       Accelerated failure time model 
(lognormal) 1.00 (0.79, 1.21) -1.00 (-1.20, -0.80) 
   Accelerated failure time model 
(exponential) 1.54 (1.30, 1.79) -0.98 (-1.22, -0.75) 
   Median survival model (Laplace 
regression) 0.99 (0.76, 1.24) -0.99 (-1.25, -0.75) 
Sample size=1,000; 20.62% censored 
Treatment of Outcome Variable 
Mean 
β0 
(5% of 
estimates, 
95% of 
estimates) 
Mean 
β1 
(5% of 
estimates, 
95% of 
estimates) 
Analyzed as a continuous outcome 
       Log-transformed linear regression 0.76 (0.70, 0.82) -0.87 (-0.93, -0.80) 
   Log-transformed median 
regression 0.77 (0.69, 0.85) -0.87 (-0.95, -0.79) 
Analyzed as a count outcome 
       Poisson regression 1.31 (1.23, 1.39) -0.80 (-0.91, -0.69) 
   Negative binomial regression 1.30 (1.22, 1.38) -0.82 (-0.90, -0.74) 
   Median regression with jittered 
outcome 0.52 (0.45, 0.60) -0.87 (-0.95, -0.79) 
Analyzed as a survival outcome 
       Accelerated failure time model 
(lognormal) 1.00 (0.94, 1.07) -1.00 (-1.07, -0.93) 
   Accelerated failure time model 
(exponential) 1.56 (1.48, 1.64) -0.97 (-1.05, -0.89) 
 61 
 
   Median survival model (Laplace 
regression) 0.99 (0.92, 1.07) -1.00 (-1.08, -0.92) 
Sample size=10,000; 20.68% censored 
Treatment of Outcome Variable 
Mean 
β0 
(5% of 
estimates, 
95% of 
estimates) 
Mean 
β1 
(5% of 
estimates, 
95% of 
estimates) 
Analyzed as a continuous outcome 
       Log-transformed linear regression 0.76 (0.74, 0.78) -0.87 (-0.89, -0.85) 
   Log-transformed median 
regression 0.77 (0.75, 0.80) -0.87 (-0.89, -0.84) 
Analyzed as a count outcome 
       Poisson regression 1.31 (1.28, 1.33) -0.80 (-0.83, -0.76) 
   Negative binomial regression 1.30 (1.28, 1.33) -0.82 (-0.85, -0.79) 
   Median regression with jittered 
outcome 0.52 (0.50, 0.55) -0.87 (-0.89, -0.84) 
Analyzed as a survival outcome 
       Accelerated failure time model 
(lognormal) 1.00 (0.98, 1.02) -1.00 (-1.02, -0.98) 
   Accelerated failure time model 
(exponential) 1.56 (1.53, 1.58) -0.97 (-0.99, -0.94) 
   Median survival model (Laplace 
regression) 0.99 (0.97, 1.02) -0.99 (-1.02, -0.97) 
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Table 5.3: Summary of analysis results with approximately 50% of the 
observations censored.  1,000 replications with β0=1 and β1=-1. 
 
Sample size=100; 49.98% censored 
Treatment of Outcome Variable 
Mean 
β0 
(5% of 
estimates, 
95% of 
estimates) 
Mean 
β1 
(5% of 
estimates, 
95% of 
estimates) 
Analyzed as a continuous outcome 
    
   Log-transformed linear regression 0.44 (0.18, 0.70) -0.78 (-1.05, -0.51) 
   Log-transformed median 
regression 0.45 (0.15, 0.77) -0.78 (-1.12, -0.45) 
Analyzed as a count outcome 
       Poisson regression 0.89 (0.60, 1.21) -0.72 (-1.13, -0.41) 
   Negative binomial regression 0.89 (0.60, 1.20) -0.74 (-1.09, -0.42) 
   Median regression with jittered 
outcome 0.20 (-0.11, 0.52) -0.78 (-1.11, -0.44) 
Analyzed as a survival outcome 
       Accelerated failure time model 
(lognormal) 1.00 (0.75, 1.26) -1.00 (-1.25, -0.76) 
   Accelerated failure time model 
(exponential) 1.51 (1.24, 1.80) -1.01 (-1.29, -0.73) 
   Median survival model (Laplace 
regression) 0.98 (0.70, 1.29) -0.99 (-1.30, 0.70) 
Sample size=1,000; 49.98% censored 
Treatment of Outcome Variable 
Mean 
β0 
(5% of 
estimates, 
95% of 
estimates) 
Mean 
β1 
(5% of 
estimates, 
95% of 
estimates) 
Analyzed as a continuous outcome 
       Log-transformed linear regression 0.43 (0.36, 0.51) -0.79 (-0.87, -0.71) 
   Log-transformed median 
regression 0.45 (0.35, 0.54) -0.78 (-0.89, -0.68) 
Analyzed as a count outcome 
       Poisson regression 0.92 (0.82, 1.02) -0.73 (-0.87, -0.61) 
   Negative binomial regression 0.92 (0.82, 1.02) -0.75 (-0.85, -0.64) 
   Median regression with jittered 
outcome 0.20 (0.10, 0.30) -0.78 (-0.88, -0.68) 
Analyzed as a survival outcome 
       Accelerated failure time model 
(lognormal) 1.00 (0.93, 1.08) -1.00 (-1.08, -0.92) 
   Accelerated failure time model 
(exponential) 1.52 (1.43, 1.60) -0.99 (-1.08, -0.90) 
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   Median survival model (Laplace 
regression) 0.98 (0.89, 1.07) -1.00 (-1.09, -0.90) 
Sample size=10,000; 50.06% censored 
Treatment of Outcome Variable 
Mean 
β0 
(5% of 
estimates, 
95% of 
estimates) 
Mean 
β1 
(5% of 
estimates, 
95% of 
estimates) 
Analyzed as a continuous outcome 
       Log-transformed linear regression 0.44 (0.41, 0.46) -0.79 (-0.81, -0.76) 
   Log-transformed median 
regression 0.45 (0.41, 0.48) -0.79 (-0.82, -0.75) 
Analyzed as a count outcome 
       Poisson regression 0.92 (0.89, 0.96) -0.74 (-0.78, -0.70) 
   Negative binomial regression 0.92 (0.89, 0.96) -0.75 (-0.78, -0.72) 
   Median regression with jittered 
outcome 0.20 (0.16, 0.23) -0.79 (-0.82, -0.75) 
Analyzed as a survival outcome 
       Accelerated failure time model 
(lognormal) 1.00 (0.98, 1.03) -1.00 (-1.02, -0.98) 
   Accelerated failure time model 
(exponential) 1.52 (1.49, 1.55) -0.99 (-1.02, -0.96) 
   Median survival model (Laplace 
regression) 0.98 (0.95, 1.01) -0.99 (-1.02, -0.97) 
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Table 5.4: Estimated impact of neonatal intensive care unit admission on hospital length of 
stay among very low birth weight infants in SC, 2004-2013. 
 
Regression Model 
Intercept 
Parameter 
Estimate 
95% CI 
NICU 
Parameter 
Estimate  
95% CI 
Log-transformed linear regression 3.06 (2.93, 3.18) 0.76 (0.69, 0.83) 
Log-transformed quantile 
regression 3.45 (3.35, 3.56) 0.43 (0.37, 0.49) 
Poisson Regression 3.60 (3.58, 3.62) 0.43 (0.42, 0.44) 
Negative Binomial Regression 3.60 (3.50, 3.69) 0.43 (0.37, 0.49) 
Quantile Regression with Jittered 
Outcome 30.32 
(25.38, 
35.26) 17.88 
(14.88, 
20.89) 
Accelerated Failure Time - 
Lognormal Model 3.12 (3.00, 3.24) 0.77 (0.70, 0.84) 
Accelerated Failure Time - 
Exponential Model 3.68 (3.55, 3.82) 0.45 (0.37, 0.54) 
Laplace Regression 33.08 
(29.35, 
36.81) 18.00 
(15.59, 
20.41) 
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Figure 5.1: Distribution of hospital length of stay among 7,252 singleton infants with a 
birth weight from 500-1,499 grams who did not have a birth defect reported on the birth 
certificate in SC, 2004-2013. 
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CHAPTER 6 
 
DELIVERY HOSPITAL LEVEL OF CARE AND LENGTH OF STAY 
AMONG VERY LOW BIRTH WEIGHT INFANTS IN SOUTH 
CAROLINA3
                                                          
3 Smith M.G., Fleischer N., Geraci M., Hale N., Hardin J.  To be submitted to Maternal 
and Child Health Journal 
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The purpose of this chapter is to examine hospital length of stay for infants in South 
Carolina by delivery hospital level of care.  As hospital length of stay is a highly skewed 
distribution, Laplace regression will be used to analyze this outcome, as determined in 
Chapter 5. 
 
Introduction 
Perinatal regionalization is a system of risk-appropriate care for women and infants.  A 
regionalized perinatal system is composed of contractual agreements between hospitals 
and health departments to ensure high-risk pregnancies and neonates can be transferred to 
facilities with the appropriate technology, sub-specialty staff, and experience to provide 
optimal care62.  Perinatal regionalization systems are often statewide and classify 
hospitals into different levels of care based on factors such as specialist and sub-specialist 
staffing, technological capability to provide advanced care, and capability to perform 
complex cardiac surgeries on newborns. The overriding objective of perinatal 
regionalization is to facilitate the appropriate transfer of women with high-risk 
pregnancies to high-level hospitals for delivery regardless of their geographic location, 
demographic factors, or ability to pay.  Perinatal regionalization systems have been 
shown to reduce the risk of neonatal mortality among very low birth weight (VLBW; 
<1,500 grams) infants when high-risk pregnancies are delivered at the highest level 
facilities8–13.  However, not all US states have perinatal regionalization systems and there 
are many differences in the way these systems operate among states that do have 
systems14,19.  
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In South Carolina (SC), hospitals licensed to care for pregnant women and deliver 
infants were divided into the following levels from 2004-2013: Level I, Level II, Level II 
Enhanced (commonly referred to as Level IIE), Level III, and Regional Perinatal Centers 
(RPCs).  Level I hospitals are small community hospitals that provide care for 
uncomplicated pregnancies expected to result in normal birth weight births (≥2,500 
grams).  Level II hospitals are larger hospitals with special care nurseries which provide 
appropriate care for uncomplicated pregnancies expected to result in a normal birth 
weight or some complicated pregnancies expected to result in a birth weight above 1,500 
grams.  Level IIE hospitals have special care nurseries with some additional capabilities 
to care for infants with a birth weight down to 1,250 grams.  Level III hospitals have 24-
hour coverage by both maternal-fetal medicine specialists and neonatologists as well as 
neonatal intensive care units (NICUs) that are equipped to provide appropriate care to 
normal or complex pregnancies and infants of any birth weight.  RPCs are Level III 
hospitals that accept high-risk pregnancies referred by other hospitals in their region, 
provide transportation for these women and infants as necessary, and provide educational 
programs to the other hospitals in their region. In SC, the criteria for hospitals to operate 
at each level of care are codified in SC State Regulation 61-16 and approved by the SC 
General Assembly55.  In 2013 there were 17 Level I hospitals, 21 Level II hospitals, one 
Level IIE hospital, and seven Level III hospitals.  Five of the seven Level III hospital 
were RPCs.  These seven Level III hospitals delivered 35.8% of all live births occurring 
in SC.   
The majority of studies on perinatal regionalization have focused on the impact of 
regionalization on neonatal mortality among VLBW infants as a proxy for high-risk 
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pregnancies8–13.  Neonatal mortality is defined as the death of a live-born infant in the 
first 27 days of life occurring in any location.  While neonatal mortality is an outcome of 
great importance, there is also a need for studies on other important outcomes32.  
Outcomes that have a clearly defined financial impact on health care payers are of 
particular relevance to the ongoing policy discussion around perinatal regionalization.  
Recent studies have examined outcomes such as necrotizing enterocolitis, neurological 
impairments, gastroschisis, and Medicaid reimbursement, comparing outcomes when 
deliveries occur in hospitals with NICUs to when deliveries occur in smaller hospitals 
and were transferred to hospitals with NICUs31,33,34.   
To the best of our knowledge, only one study to date has assessed the association 
of hospital of birth and hospital length of stay (HLS) in the context of a regionalized 
system of perinatal care13.  This study, published by Sanderson et al. in 2000, examined 
the association between the level of care of the hospital of delivery and neonatal 
mortality, HLS, and Medicaid reimbursement among Medicaid deliveries in SC.  This 
study evaluated length of stay as a continuous outcome using linear regression with a log-
transformed outcome to account for non-normality in the HLS variable. While this 
approach was often used to analyze this type of outcome at the time of its publication, it 
does have limitations that could result in biased estimates, especially if a high percentage 
of the HLS outcomes are censored due to infant mortality or transfer to facilities not 
included in the available data.  A variety of additional analysis methods may be applied 
in assessing HLS outcomes.  Therefore, the most appropriate analytic method for 
assessing the impact on HLS for VLBW infants delivered in Level III or higher hospital 
warrants additional consideration. 
 70 
 
 A HLS may be appropriately considered a time-to-event outcome that can be 
analyzed using survival analysis methods, including Cox proportional hazards regression, 
accelerated failure time regression, and Laplace regression.  Using a survival analysis 
approach to HLS also has the advantage of being able to consider HLS values that do not 
end in a discharge as censoring events.  Examples of such censoring events could include 
hospital stays that end in a transfer to a facility outside the study area or hospital stays 
that end in death.  A few studies have used survival analysis to examine HLS as an 
outcome using both semi-parametric (Cox proportional hazards regression)44–46 and 
parametric (accelerated failure time regression) models45,47,48.  Some recent studies 
applied quantile regression to model HLS either as a continuous variable49–52 or as count 
data53.  Finally, at least one study used Laplace regression to model HLS among the 
elderly in Sweden as a survival outcome for quantiles of interest54.  With HLS as a 
survival outcome, Cox proportional hazards regression assesses the relative probability of 
discharge (hazard) at a given time across levels of a predictor variable.  While this is 
useful information, we are most interested in the estimated absolute survival times across 
levels of a predictor rather than the relative hazard.  Using an accelerated failure time 
regression analysis would provide the estimated mean time until hospital discharge across 
levels of a predictor, but requires the assumption of an underlying distribution giving rise 
to the length of stay data.  If an incorrect underlying distribution is assumed, substantial 
bias may be introduced.  Modeling conditional quantiles, using quantile regression or 
Laplace regression, provides the opportunity to examine the estimated time until 
discharge across levels of a predictor for multiple points across the entire distribution of 
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the outcome, including the tails, not only the central part (e.g., the mean) without 
specifying a distributional assumption.   
 This paper investigates the association between the delivery hospital level of care 
(the exposure) and HLS (the outcome) at the left tail (5th and 10th centiles), the center 
(25th, 50th and 75th centiles), and the right tail (90th and 95th centiles) of the outcome 
distribution using Laplace regression.  Using this method, we are able to explore: (1) 
whether delivery in a Level III hospital is associated with increased or decreased median 
HLS among VLBW infants born in SC as compared to delivery in Level I hospitals and 
Level II hospitals, and (2) whether the strength and direction of the association is the 
same depending on the length of hospital stays (conditionally based on the covariates 
included).  We hypothesize that delivery in a Level I or Level II hospital will result in 
longer HLS, especially at the central and right-tailed centiles, as suggested by Sanderson 
et al13.  This analysis will help to inform whether well-regulated regionalized systems of 
perinatal care are associated with reduced cost by way of shorter hospital stays among 
VLBW infants in addition to reducing the risk of neonatal mortality, which has been 
previously established8–13. 
Methods 
Population 
This observational analysis utilizes a linked data file that includes data on live births and 
delivery hospital stays among SC residents delivering in SC from 2004-2013.  This 
linked file includes data from the SC Certificate of Live Birth (2003 US Standard 
revision) and hospital discharge uniform billing data for all live births occurring in a SC 
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hospital.  The analyses presented in this manuscript are restricted to VLBW deliveries 
occurring in SC hospitals.  Live births with a birth weight less than 500 grams have been 
removed from all analyses so that these results are comparable to other studies of 
perinatal regionalization, as these births are generally considered to be non-viable and are 
at high risk for in-hospital death no matter where they were delivered.  Furthermore, data 
are restricted to singleton deliveries without a birth defect indicated in birth certificate 
data.  For multivariable analyses, only complete records were included (a total of 179 
records with missing pre-pregnancy height or weight and 1 record with a missing 
maternal age were excluded).  Figure 6.1 depicts the number of observations excluded 
due to each criteria and the composition of the final analysis dataset (n=6,301). 
 A sensitivity analysis including deliveries weighing less than 500 grams was also 
conducted. 
Variables 
The outcome of primary interest in these analyses is the HLS immediately following 
delivery.  This outcome variable is assessed from hospital discharge data.  Some infants 
were transferred directly from one hospital to another.  In the event that an infant was 
discharged from one hospital with a discharge disposition that indicated a transfer and the 
same infant was admitted to a different hospital on the same date, these values were 
summed and considered to be a single HLS.  There were three endpoints in the data that 
could result in the end of a hospital stay: a discharge disposition indicating that the infant 
was discharged from the hospital; a discharge disposition indicating the infant was 
transferred, but no record of admission to another hospital in SC; and a discharge 
disposition indicating death or a date of death that coincides with end of a hospitalization. 
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The exposure of interest is the level of perinatal care of the hospital of delivery.  
This three-level variable was coded as delivery in a Level III hospital (including RPCs as 
Level III hospitals), delivery in a Level II hospital, or delivery in a Level I hospital.  One 
hospital in SC was licensed at the Level IIE designation for the years under study.  This 
hospital was licensed to deliver infants expected to weigh 1,250g or more.  To prevent 
identifying a single facility, the hospital level of care was recoded for VLBW infants 
born in this hospital with infants weighing 1,250-1,499g (infants this facility was licensed 
to deliver) being coded as being born in a Level III hospital and infants weighting less 
than 1,250g (infants this facility was not licensed to deliver) being coded as being born in 
a Level II facility.  
The following variables are included as confounders, with hypothesized 
associations with HLS illustrated in the directed acyclic graph in Figure 6.2: maternal age 
(<18 years, 18-24 years, 25-34 years, ≥35 years; birth certificate data), maternal race 
(non-Hispanic White, non-Hispanic Black, Hispanic, and other; birth certificate data), 
initiation of prenatal care in the first trimester of pregnancy (yes, no; birth certificate 
data), method of delivery payment (private insurance, Medicaid, self-pay or other; birth 
certificate data), pre-pregnancy obesity status (obese [BMI≥30 kg/m2], overweight 
[25≤BMI<30 kg/m2], or normal/underweight [BMI<25 kg/m2]; birth certificate data 
[height and weight for birth data are self-reported]), gestational diabetes (yes, no; birth 
certificate data), gestational hypertension or pre-eclampsia (yes, no; birth certificate 
data), surfactant replacement therapy during pregnancy (yes, no; birth certificate data), 
corticosteroid use during pregnancy (yes, no; birth certificate data), assisted ventilation 
for newborn (yes, no; birth certificate data), and neonatal intensive care unit (NICU) 
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admission (yes, no; birth certificate data).  A greater proportion of VLBW infants 
delivering at Level III hospitals in the study population were admitted to NICUs (85.7%, 
53.5%, and 50.9% of VLBW infants born in Level III, Level II, and Level I hospitals, 
respectively) and infants admitted to NICUs tended to have longer HLS (a median of 55 
days HLS among VLBW NICU admissions compared to a median of 33 days HLS 
among VLBW non-NICU admissions). Therefore, an interaction between hospital level 
of care and NICU admission was also assessed. 
 Gestational age at delivery was not included as a covariate because nearly all of 
the live births included in this study were delivered preterm with over 80% of all 
deliveries being early preterm (<32 weeks of gestation).  However, a sensitivity analysis 
including gestational age was conducted. 
Statistical analysis 
To explore the relationship between each covariate and the time until hospital discharge, 
each characteristic hypothesized to be associated with the outcome was assessed by first 
examining its pairwise association with HLS, while accounting for censoring due to 
transfers without readmissions in SC and in-hospital deaths.  The mean and median HLS 
for each level of all covariates were considered.  Bivariate associations were assessed 
using log-rank tests. 
 Laplace regression was used to assess the difference in HLS in days among 
VLBW infants delivered in Level I hospitals and Level II hospitals compared to VLBW 
infants delivered in Level III hospitals (reference level).  The association of delivery 
hospital level of care was examined at the 5th, 10th, 25th, 50th, 75th, 90th, and 95th centiles 
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of the conditional distribution of HLS. We chose these centiles so as to study the central 
part of the distribution (25th, 50th and 75th centiles) as well as the observations on the left 
(5th and 10th) and right (90th and 95th) tails of the distribution. 
The standard linear quantile regression (QR) model60 at probability level p is 
defined as  
𝑄(𝑝) = 𝛽0(𝑝) + 𝛽1(𝑝)𝑥1 + ⋯ + 𝛽𝑘(𝑝)𝑥𝑘, 
where 𝑄(𝑝) denotes the pth quantile of the outcome conditional on the covariates 𝑥1, …, 
𝑥𝑘 and 𝛽0(𝑝), …, 𝛽𝑘(𝑝) are regression coefficients specific to the quantile of interest. In 
contrast to mean regression, the goal of QR is to predict specific quantiles of the 
conditional distribution of the outcome (e.g., the median, 25th percentile, 95th percentile) 
rather than the mean. Moreover, inference on conditional quantiles is robust to different 
shapes of the error distribution, including skewed and heavy-tailed distributions, while 
mean regression relies on normality assumptions.  Laplace regression extends the 
quantile regression model to censored data where the outcome under study is 𝑌 =
min(𝑇, 𝐶), where T is the time until hospital discharge and C is the time until censoring 
due to transfer without readmission within SC or in-hospital death.   
 Additional details on quantile regression and Laplace regression are available 
elsewhere60,61.  All data management was conducted in SAS 9.3 (Cary, NC) and all 
analyses were conducted in Stata 12 (College Station, TX).  Laplace regression was 
implemented in Stata using the Laplace package downloaded from 
http://www.imm.ki.se/biostatistics/stata.  Confidence intervals for Laplace regression 
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coefficients were calculated by bootstrap resampling with 200 replicates.  The 
significance level was set at 5%. 
Results 
The distribution of HLS among singleton VLBW infants born in SC hospitals without 
reported congenital anomalies is highly skewed to the right (Figure 6.3).  As a result of 
this skewness, the mean HLS (56 days) is one week longer than the median HLS (49 
days) (Table 6.1).  Furthermore, there is substantial variability in HLS among VLBW 
infants born in SC with a standard deviation of 36.7 days and first and third quartiles 
from 32 days to 75 days. 
 Substantial differences are observed in HLS when stratifying by the two 
censoring events: infant death and transfer without readmission (Table 6.1).  Infants who 
were discharged had substantially longer median HLS (48 days) than infants who died 
prior to discharge (10 days) or infants who were transferred without readmission in SC (1 
day).  Overall, 10.7% of VLBW infants in the study population died prior to hospital 
discharge and 3.6% were transferred without readmission in SC. 
Bivariate Results 
The mean and median lengths of hospital stay by maternal and infant characteristics are 
presented in Table 6.2.  Statistically significant bivariate associations were observed 
between HLS and maternal age, delivery hospital level of care, gestational diabetes, 
gestational hypertension, surfactant replacement therapy, assisted infant ventilation, and 
NICU admission. 
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 For the exposure, delivery hospital level of care, infants born at Level III hospitals 
had a longer median HLS (51 days) than infants born in Level II hospitals (41.5 days), 
and infants born in Level I hospitals (39 days).  Kaplan Meier survival curves depicting 
the time until hospital discharge, death, or transfer without readmission in SC is 
displayed by hospital level of care in Figure 6.4.  
Multivariable Results 
Table 6.3 shows estimated 5th, 10th, 25th, 50th, 75th, 90th, and 95th Laplace regression 
coefficients and their 95% confidence intervals. Each coefficient can be interpreted as the 
difference between the HLS at the specified centile for the given hospital level of care 
and HLS for deliveries in Level III hospital, conditional on the covariates. The crude 
estimates of the association between hospital level of care and HLS indicate that VLBW 
infants born in Level I and II hospitals have shorter HLS at or below the 50th centile when 
compared to VLBW infants born in Level III hospitals.  Meanwhile, a significant 
difference in HLS between Level I or Level II hospitals and Level III hospitals was not 
detected at or above the 90th centile.  However, the estimated coefficients adjusted for 
confounding differed somewhat from the crude estimates, especially at lower centiles.  
After adjusting for all confounders as reported in Figure 6.2, VLBW infants born in 
Levels I and II hospitals tended to have significantly shorter HLS than VLBW infants 
born in Level III hospitals at lower quantiles of their respective HLS distributions (5th and 
10th centiles). VLBW infants born in Level II hospitals also had significantly shorter HLS 
than those born in Level III hospitals for central conditional quantiles (i.e., 25th, 50th and 
75th), although there were no significant differences between conditional HLS in Level I 
and Level III hospitals for the central conditional quantiles.  There were no significant 
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differences between conditional HLS in Level I or Level II deliveries as compared to 
deliveries in Level III hospitals at the 90th or 95th centiles.  A test for interaction between 
delivery hospital level of care and NICU admission was non-significant (p≥0.6 for all 
quantiles modelled) and, therefore, this interaction was dropped from the final model. 
 Results from sensitivity analyses including VLBW infants with a birth weight less 
than 500g and adjusting for gestational age at delivery were similar to the results 
presented in Table 6.3.   
Discussion 
Overall, the delivery hospital level of care was associated with HLS among VLBW 
infants born in SC at the shortest and central conditional quantiles.  The shortest HLS 
among VLBW infants delivered in Level I and Level II hospitals (5th and 10th centiles) 
were shorter than the shortest HLS among VLBW infants delivered in Level III hospitals 
(5th and 10th centiles). The 25th, 50th, and 75th centiles of HLS were shorter in Level II 
hospitals than Level III hospitals, but there were no significant differences in HLS at 
these quantiles between Level I and Level III hospitals.  The 90th and 95th centiles of HLS 
were not significantly different between Level I or Level II hospitals and Level III 
hospitals. 
There are a few possible explanations for these observed results.  Because the 
Perinatal Regionalization System in SC was consistent with the Guidelines for Perinatal 
Care for the period under study62, with these guidelines codified in state regulation55, 
infants born in Level I and Level II hospitals could be a mix of highest and lowest risk 
VLBW infants. As shown previously, VLBW infants delivering in Level I and Level II 
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hospitals have greater neonatal mortality8–13, leading to a greater number of censored 
observations, usually at short hospital lengths of stay. Level I and Level II hospitals also 
consult with Level III hospitals before transferring mothers for delivery and sometimes 
decide that the best care could be provided by the Level I or Level II hospital closer to the 
patients’ residences.  Therefore, Level I and Level II hospitals may be more likely to 
keep lower risk VLBW deliveries.  This is especially plausible for Level II hospitals, as 
they often employ neonatologists and have better capacity to care for infants born near 
1,500g than Level I hospitals.  The premise that Level I and Level II hospitals have a 
greater prevalence of highest and lowest risk VLBW deliveries is supported by the fact 
that, when excluding multiple births and congenital anomalies, a greater proportion of 
VLBW births in Level I and Level II hospitals are less than 500g (15.3% and 18.2%, 
respectively) compared to Level III hospitals (8.6%), and a greater proportion of VLBW 
births in Level II hospitals are also between 1,400g and 1,499g (13.7%) than in Level III 
hospitals (11.0%; based on analysis of study data). 
The results presented here differ from the results observed by Sanderson et al. for 
VLBW births from 1991 to 1995 in SC, who found that mean HLS were shorter for 
infants born in Level III hospitals13.  However, there are some key differences between 
our study and the study conducted by Sanderson et al.  Sanderson et al’s study was 
restricted to infants whose delivery was paid for by Medicaid. Moreover, they applied 
linear regression to log-transformed HLS and results were then back-transformed to 
predict mean HLS.  While this approach is often used with linear regression to account 
for skewed outcome variables, back-transformation of parameter estimates via 
exponentiation can be misleading because exponentiated estimates are relative to the 
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geometric mean rather than the arithmetic mean as usually intended. Our study included 
all live births and used a distribution-robust approach to examine the association of 
delivery hospital level of care on the entire distribution of the outcome.  This study adds 
additional context to the work by Sanderson et al. in that these results indicate that the 
association between delivery hospital level of care and HLS differs for the shortest 
conditional HLS values, the central HLS values, and the longest HLS values. 
Our study is subject to several limitations.  First, as with any observational study, 
there may be uncontrolled confounding that could change the nature of the observed 
association if appropriately considered since only variables included on birth certificates 
and hospital discharge data were available. An accurate measure for preterm labor was 
not available, as it does not always result in a preterm birth and preterm births do not 
always proceed from spontaneous preterm labor.  While preterm labor is a potential 
unmeasured confounder, adjusting for the variables associated with preterm labor, as 
shown in Figure 6.2, results in no hypothesized confounding of the association between 
delivery hospital level of care and HLS due to preterm labor.  An additional limitation is 
that most of the variables used in this study are based on birth certificate data, which have 
been shown in SC to have low sensitivity for some variables when compared to medical 
records; however, most of the variables used in this study have been shown to have 
substantial or high sensitivity58.  The quality of HLS assessment in SC hospital discharge 
data is unknown.   
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Conclusions 
This study demonstrates the additional insight that can be gained by utilizing statistical 
methods that examine various points across the outcome distribution.  Associations at the 
highest and lowest conditional quantiles are often relevant to health policy discussions, 
but may be lost because the appropriate statistical methods are not used as frequently.  
Taking the results of this study into consideration, while HLS may be shorter in Level I 
and Level II hospitals at lower quantiles of the HLS distribution, possibly leading to 
lower costs, this does not outweigh the increased risk of neonatal mortality which has 
been shown repeatedly in the literature.  Cost savings obtained by the marginal reduction 
in relatively short HLS values is insufficient justification for recommendations to 
discontinue perinatal regionalization systems that have been associated with decreasing 
neonatal deaths among some of the highest risk newborns.  Therefore, continuing to 
support well-regulated systems of perinatal regionalization remains important to ensure 
optimal birth outcomes for high-risk pregnancies.   
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Table 6.1: Descriptive summary of length of hospital stay by censoring 
variables among live births occurring in SC hospitals, 2004-2013. 
 
Characteristic N Mean (SD*) Median 
(Q1, 
Q3**) 
In-Hospital Infant Death 
        No 6098 54.1 (37.6) 48 (30, 74) 
   Yes 773 32.0 (49.5) 10 (1, 40) 
Transfer without Readmission within 
SC 
        No 6608 53.0 (39.2) 46 (27, 73) 
   Yes 263 16.5 (36.1) 1 (1, 20) 
Overall 6871 51.6 (39.7) 45 (25, 71) 
*Standard deviation 
     **First (Q1) and third (Q3) quartiles 
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Table 6.2: Descriptive summary of length of hospital stay by delivery characteristics 
among live births occurring in SC hospitals, 2004-2013.  Censored observations 
excluded. 
 
Characteristic N Mean (SD*) Median 
(Q1, 
Q3**) 
P-
Value^ 
Maternal Age 
      
   <18 years 552 56.1 (36.5) 48 
(33.5, 
74) 
0.02    18-24 years 2,109 53.5 (35.6) 47 (30, 71) 
   25-34 years 2,466 56.8 (37.1) 50 (32, 77) 
   ≥35 years 707 59.2 (38.6) 53 (35, 78) 
Hospital Level of Care 
         Level I 167 49.7 (38.0) 39 (23, 72) 
<0.0001    Level II 546 47.1 (37.6) 41.5 (22, 65) 
   Level III 4,806 58.0 (36.5) 51 (34, 76) 
Maternal Race/Ethnicity 
         Non-Hispanic White 1,965 55.8 (34.5) 51 (32, 75) 
0.62    Non-Hispanic Black 3,444 55.7 (38.0) 48 (31, 75) 
   Hispanic/Other 426 56.8 (36.5) 51 (34, 74) 
Prenatal Care in the First 
Trimester 
         No 1,954 54.0 (36.1) 47 (30, 72) 
0.21 
   Yes 3,881 56.7 (37.1) 50 (33, 76) 
Method of Delivery Payment 
         Medicaid 3,635 55.7 (37.8) 48 (32, 74) 
0.63    Private Insurance 1,468 56.5 (34.2) 51 (33, 76) 
   Self-Pay/Other 730 54.9 (36.4) 48.5 (31, 76) 
Body Mass Index Classification 
         Underweight/Normal Weight 2,279 55.1 (36.5) 48 (32, 73) 
0.36    Overweight 1,317 55.5 (37.0) 49 (31, 75) 
   Obese 2,079 57.0 (36.7) 51 (33, 76) 
Gestational Diabetes 
         No 5,568 56.0 (37.0) 49 (32, 75) 
0.002 
   Yes 267 51.1 (30.4) 47 (31, 66) 
Gestational Hypertension 
         No 4,715 57.4 (36.7) 51 (33, 77) 
<0.0001 
   Yes 1,120 49.2 (36.0) 41 
(27, 
61.5) 
Surfactant Replacement Therapy 
         No 4,490 52.8 (35.4) 46 (29, 70) 
<0.0001 
   Yes 1,338 66.1 (39.0) 61 (41, 84) 
Antenatal Steroids 
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   No 4,873 55.8 (37.6) 49 (32, 75) 
0.26 
   Yes 962 55.7 (32.1) 50 (33, 76) 
Assisted Ventilation for Infant 
      
   No 3,392 52.9 (35.9) 46 
(29, 
70.5) <0.0001 
   Yes 2,443 59.9 (37.5) 54 (36, 79) 
NICU Admission 
     
 
   No 667 37.8 (32.6) 33 (16, 53) 
<0.0001 
   Yes 5,168 58.1 (36.6) 51 (34, 77) 
Overall 5,835 55.8 (36.7) 49 (32, 75)   
*Standard deviation 
      **First (Q1) and third (Q3) 
quartiles 
      ^P-values from the log-rank test. 
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Table 6.3: Adjusted difference in length of hospital stay by hospital level of care at 
the 5th, 10th, 25th, 50th, 75th, 90th, and 95th quantiles.  Results from Laplace regression 
among live births in SC hospitals, 2004-2013 (n=6,301). 
 
Hospital 
Level of 
Care 
Crude Difference in 
HLS (Days) 95% CI 
Adjusted* 
Difference in HLS 
(Days) 
95% CI 
5th Percentile 
Level I -11.8 (-14.9, -8.6) -10.5 (-17.6, -3.4) 
Level II -13.0 (-14.5, -11.6) -11.1 (-15.3, -6.9) 
Level III Ref. 
 
Ref. 
 10th Percentile 
Level I -16.8 (-24.0, -9.6) -8.7 (-13.3, -4.2) 
Level II -19.9 (-21.9, -17.9) -9.5 (-12.9, -6.1) 
Level III Ref. 
 
Ref. 
 25th Percentile 
Level I -8.0 (-14.6, -1.4) -3.7 (-8.5, 1.2) 
Level II -11.8 (-14.3, -9.2) -7.8 (-10.9, -4.7) 
Level III Ref. 
 
Ref. 
 50th Percentile 
Level I -9.0 (-14.7, -3.3) -4.8 (-10.8, 1.2) 
Level II -9.7 (-12.4, -6.9) -6.9 (-9.5, -4.3) 
Level III Ref. 
 
Ref. 
 75th Percentile 
Level I -0.8 (-11.3, 9.7) -3.8 (-14.4, 6.8) 
Level II -9.0 (-14.1, -3.9) -5.7 (-11.0, -0.5) 
Level III Ref. 
 
Ref. 
 90th Percentile 
Level I 7.6 (-10.1, 25.2) 9.7 (-11.0, 30.3) 
Level II -1.6 (-7.5, 4.2) -1.3 (-11.2, 8.7) 
Level III Ref. 
 
Ref. 
 95th Percentile 
Level I 16.6 (-7.5, 40.7) 8.1 (-12.4, 28.7) 
Level II -3.5 (-16.7, 9.7) 1.8 (-11.9, 15.5) 
Level III Ref.   Ref.   
*Laplace model adjusted for maternal age, maternal race/ethnicity, entry into prenatal care in 
the first trimester, method of delivery payment, obesity status, gestational diabetes, 
gestational hypertension, surfactant replacement therapy, antenatal steroids, and assisted 
ventilation for the infant. 
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Figure 6.1: Sample size and exclusions for final set of deliveries included in analyses. 
9,500 live births <1,500g with a hospital stay of at 
least one night 
540 live births <500g 
8,960 live births 500-1,499g with a hospital stay of 
at least one night 
470 births occurring outside a 
SC hospital 
8,490 live births 500-1,500g with a SC hospital stay of at 
least one night 
1,923 twins or higher order 
multiples 
6,567 singleton live births 500-1,500g with a SC hospital 
stay of at least one night 
86 reported congenital 
anomalies 
6,481 singleton live births 500-1,500g with a SC hospital 
stay of at least one night  
179 with missing values for 
pre-pregnancy BMI, 1 missing 
values for maternal age 
6,301 singleton live births 500-1,499g with a SC hospital 
stay of at least one night 
(219 hospital stays ending with a transfer without 
readmission in SC, 709 hospital stays ending with an in-
hospital death, and 5,373 hospital stays ending with a 
discharge event)  
  
 
8
7
 
 
Figure 6.2: Directed acyclic graph (DAG) for the relationship between level of perinatal care for the hospital of delivery and length of 
hospital stay.
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CHAPTER 7 
CONCLUSIONS
The purpose of this chapter is to present overall conclusions in consideration of all 
analyses conducted in this dissertation. 
 
Summary 
The perinatal regionalization system in SC seeks to provide a series of mechanisms by 
which women with high-risk pregnancies can be transferred to a Level III hospital with a 
NICU prior to delivery.  Hospitals in SC are licensed by the state to provide perinatal 
care at a certain level with seven hospitals licensed as Level III hospitals from 2004-
201355.  This licensing structure has allowed SC to have a consistent perinatal 
regionalization structure for decades, affording adequate sample size to study the impact 
of this system in a small population such as VLBW births.  This dissertation presents a 
series of analyses to assess the impact of perinatal regionalization on birth outcomes of 
interest among VLBW infants delivered in SC hospitals from 2004-2013.  The birth 
outcomes under study in this dissertation were neonatal mortality and HLS. 
 Chapter 4 of this dissertation assessed the association between delivery in a non-
Level III hospital and neonatal mortality while accounting for fetal deaths as censored 
events.  This study was based on 8,594 live births and fetal deaths occurring in SC 
 89 
 
hospitals with a birth weight from 500 to 1,500 grams from 2004-2013.  Among this 
population, 6,726 observations were live births (of which 600 resulted in a neonatal 
death) and 1,868 were fetal deaths.  Marginal structural modelling was used to estimate 
that VLBW infants delivered in a non-Level III hospital were at 1.81 times the risk of 
neonatal mortality than VLBW infants delivered in a Level III hospital when accounting 
for fetal deaths as censored observations (Table 4.3).  This result is compared to a 1.62 
fold increase in risk for VLBW infants delivered in a non-Level III hospital when fetal 
deaths were not accounted for as censored observations.  Thus, failing to account for 
censoring due to fetal death resulted in an estimated risk of neonatal death that was 
10.5% below the estimate when fetal deaths were considered censored observations.   
Considering fetal deaths to be censored events for the neonatal mortality outcome 
is important because fetal death is an outcome that can be caused by many of the risk 
factors for neonatal death and also prevents an observation from being a neonatal death 
(as shown in Figure 4.1).  Therefore, the results of these analyses indicate that failing to 
account for fetal deaths as censored events when examining the impact of perinatal 
regionalization systems on neonatal mortality may underestimate the strength of the 
association. 
A birth outcome that may be of interest when examining the impact of many 
potential interventions is HLS.  This outcome is especially pertinent given the focus of 
many health care systems on the Institute for Healthcare Improvement’s Triple Aim to 
improve health, improve clinical care, and reduce cost59.  However, there is a lack of a 
consistent analysis strategy in the current literature for examining highly skewed 
outcomes such as HLS.  Some studies have analyzed HLS outcomes as continuous 
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variables using linear regression with a log-transformed outcome36–39 and using quantile 
regression49–52.  Other studies have analyzed HLS as a count outcome with Poisson or 
negative binomial regression40–43 or quantile regression extended for count outcomes 
using a process called jittering53.  Still other studies have analyzed HLS as a time-to-
event (i.e., survival) outcome using Cox proportional hazards regression44–46, AFT 
regression45,47,48, or Laplace regression54.   
Chapter 5 of this dissertation sought to simulate highly skewed outcomes, similar 
to HLS, and apply several of these analysis methods to determine which is the most 
effective at correctly estimating the intercept and slope parameters in simple regression 
models.  The highly skewed outcome was simulated using a log-normal distribution and 
separate log-normal distributions were used to censor a subset of the simulated outcomes.  
Simulated datasets were generated 1,000 times for nine different scenarios.  These 
scenarios varied by sample size (100 observations, 1,000 observations, and 10,000 
observations) and the prevalence of censoring (roughly 8% of all outcomes censored, 
roughly 20% of all outcomes censored, and roughly 50% of all outcomes censored).   
When assessing the results of the analyses of these simulated datasets, analyzing 
the highly skewed outcome as a time-to-event variable consistently produced the most 
accurate estimates.  In particular, using an AFT regression model with the correct 
underlying distribution specified (log-normal in this case) was the most efficient at 
correctly estimating the parameters of interest, with Laplace regression also estimating 
the parameters accurately but with slightly less efficiency in terms of observed standard 
deviations of the estimates.  However, using an AFT regression model with the incorrect 
underlying distribution specified (exponential was specified in this case instead of log-
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normal), the estimate of the intercept parameter was substantially biased while the 
estimate of the slope parameter was slightly biased.  Therefore, this chapter recommends 
using Laplace regression to analyze highly skewed outcomes unless the underlying 
distribution giving rise to the outcome is confidently known, in which case using an AFT 
regression model with the correct distribution specified would be preferable. 
Chapter 6 of this dissertation used Laplace regression to assess HLS for VLBW 
infants born in Level I and Level II hospitals compared to infants born in Level III 
hospitals for live births occurring in 2004-2013.  Laplace regression was used based on 
the results of Chapter 5 because the underlying distribution giving rise to HLS data 
among VLBW infants born in SC hospitals from 2004-2013 was not confidently known.  
An attractive function of Laplace regression is that it allows for the examination of the 
association between HLS and hospital level of care across conditional quantiles of the 
HLS distribution.  The 5th, 10th, 25th, 50th, 75th, 90th, and 95th conditional centiles of HLS 
were compared between Level I VLBW births and Level III VLBW births as well as 
between Level II VLBW births and Level III VLBW births.  This analysis included 6,301 
infants born between 500 and 1,500 grams in SC hospitals from 2004-2013.  Among 
these deliveries, 5,373 ended with a hospital discharge, 709 ended with an in-hospital 
death, and 219 ended with a transfer without readmission in SC.   
The results of these analyses indicate that the 5th and 10th centiles of HLS among 
VLBW infants delivered in Level I and Level II hospitals were shorter than those 
delivered in Level III hospitals.  Additionally, the 25th, 50th, and 75th centiles of HLS 
among VLBW infants delivered in Level II hospitals were shorter than those delivered in 
Level III hospitals.  Finally, there was no significant difference in HLS between VLBW 
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infants delivered in Level I or Level II hospitals and VLBW infants delivered in Level III 
hospitals for the 90th and 95th centiles.  These results indicate that HLS is shorter among 
VLBW infants born in non-Level III hospitals for shorter lengths of stay and that HLS is 
shorter among VLBW infants born in Level II hospitals for central lengths of stay, 
compared to VLBW infants born in Level III hospitals, but that no difference in HLS is 
observed across levels of perinatal care for longer lengths of stay. 
Overall, the results presented in Chapters 4-6 indicate that VLBW infants 
delivered in non-Level III hospitals are at increased risk of neonatal death when 
accounting for censoring due to fetal deaths, but that those delivered at non-Level III 
facilities may have shorter HLS for relatively short or central HLS values.  The cost 
savings potentially realized by shorter HLS for relatively short or central HLS values do 
not outweigh the substantial increase in neonatal mortality observed for VLBW infants 
delivered in non-Level III hospitals in SC.  Therefore, it is strongly recommended that SC 
continue to support the statewide perinatal regionalization system and ensure that every 
possible high-risk pregnancy deliver in a Level III hospital. 
 These results may also hold for other states with hospital levels of prenatal care 
criteria outlined in state regulations and tied to hospital licensing.  However, these results 
could also be compared to similar results from other states with perinatal regionalizataion 
systems that are not as strictly regulated to help assess the impact of state perinatal 
regulations.  
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